BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Petta S, Cammà C, Scazzone C, Tripodo C, Di Marco V, Bono A, Cabibi D, Licata G, Porcasi R, Marchesini G, Craxí A. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology 2010;51:1158-67. [PMID: 20162613 DOI: 10.1002/hep.23489] [Cited by in Crossref: 298] [Cited by in F6Publishing: 292] [Article Influence: 24.8] [Reference Citation Analysis]
Number Citing Articles
1 Meer AJ, Maan R, Knegt RJ, Veldt BJ. Natural History of HCV-induced Liver Disease. Curr Hepatitis Rep 2013;12:251-60. [DOI: 10.1007/s11901-013-0195-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
2 Triantos C, Aggeletopoulou I, Thomopoulos K, Mouzaki A. Vitamin D-Liver Disease Association: Biological Basis and Mechanisms of Action. Hepatology 2021;74:1065-73. [PMID: 33405236 DOI: 10.1002/hep.31699] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
3 Reiter FP, Hohenester S, Nagel JM, Wimmer R, Artmann R, Wottke L, Makeschin MC, Mayr D, Rust C, Trauner M. 1,25-(OH)2-vitamin D3 prevents activation of hepatic stellate cells in vitro and ameliorates inflammatory liver damage but not fibrosis in the Abcb4(-/-) model. Biochem Biophys Res Commun. 2015;459:227-233. [PMID: 25712522 DOI: 10.1016/j.bbrc.2015.02.074] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
4 Trinks J, Hulaniuk ML, Redal MA, Flichman D. Clinical utility of pharmacogenomics in the management of hepatitis C. Pharmgenomics Pers Med 2014;7:339-47. [PMID: 25382982 DOI: 10.2147/PGPM.S52624] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Dadabhai AS, Saberi B, Lobner K, Shinohara RT, Mullin GE. Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data. World J Hepatol 2017; 9(5): 278-287 [PMID: 28261385 DOI: 10.4254/wjh.v9.i5.278] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
6 Bae M, Park YK, Lee JY. Food components with antifibrotic activity and implications in prevention of liver disease. J Nutr Biochem 2018;55:1-11. [PMID: 29268106 DOI: 10.1016/j.jnutbio.2017.11.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
7 Falleti E, Cmet S, Fabris C, Fattovich G, Cussigh A, Bitetto D, Ceriani E, Lenisa I, Dissegna D, Ieluzzi D. Genetic polymorphisms of vitamin D pathway predict antiviral treatment outcome in slow responder naïve patients with chronic hepatitis C. PLoS One. 2013;8:e80764. [PMID: 24244713 DOI: 10.1371/journal.pone.0080764] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
8 Ali ME, Halby HM, Ali MY, Hassan EA, El-Mokhtar MA, Sayed IM, Thabet MM, Fouad M, El-Ashmawy AM, Mahran ZG. Role of Serum Vitamin D, Interleukin 13, and microRNA-135a in Hepatocellular Carcinoma and Treatment Failure in Egyptian HCV-Infected Patients Receiving Direct Antiviral Agents. Viruses 2021;13:2008. [PMID: 34696438 DOI: 10.3390/v13102008] [Reference Citation Analysis]
9 Okubo T, Atsukawa M, Tsubota A, Shimada N, Abe H, Yoshizawa K, Arai T, Nakagawa A, Itokawa N, Kondo C. Association between vitamin D deficiency and pre-existing resistance-associated hepatitis C virus NS5A variants. Hepatol Res. 2017;47:641-649. [PMID: 27487797 DOI: 10.1111/hepr.12784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
10 Kitson MT, Dore GJ, George J, Button P, Mccaughan GW, Crawford DH, Sievert W, Weltman MD, Cheng WS, Roberts SK. Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection. Journal of Hepatology 2013;58:467-72. [DOI: 10.1016/j.jhep.2012.11.017] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 5.9] [Reference Citation Analysis]
11 Putz-Bankuti C, Pilz S, Stojakovic T, Scharnagl H, Pieber TR, Trauner M, Obermayer-Pietsch B, Stauber RE. Association of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease. Liver Int. 2012;32:845-851. [PMID: 22222013 DOI: 10.1111/j.1478-3231.2011.02735.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 6.7] [Reference Citation Analysis]
12 Zhang L, Chu YJ, Lin S, Wang J. Comparison of peripheral blood T lymphocyte subsets in chronic hepatitis B patients with different serum 25-hydroxyvitamin D levels. Shijie Huaren Xiaohua Zazhi 2015; 23(2): 267-271 [DOI: 10.11569/wcjd.v23.i2.267] [Reference Citation Analysis]
13 Masri OA, Chalhoub JM, Sharara AI. Role of vitamins in gastrointestinal diseases. World J Gastroenterol 2015; 21(17): 5191-5209 [PMID: 25954093 DOI: 10.3748/wjg.v21.i17.5191] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 25] [Article Influence: 4.9] [Reference Citation Analysis]
14 Teymoori-Rad M, Shokri F, Salimi V, Marashi SM. The interplay between vitamin D and viral infections. Rev Med Virol 2019;29:e2032. [PMID: 30614127 DOI: 10.1002/rmv.2032] [Cited by in Crossref: 103] [Cited by in F6Publishing: 87] [Article Influence: 34.3] [Reference Citation Analysis]
15 Zhu L, Kong M, Han YP, Bai L, Zhang X, Chen Y, Zheng S, Yuan H, Duan Z. Spontaneous liver fibrosis induced by long term dietary vitamin D deficiency in adult mice is related to chronic inflammation and enhanced apoptosis. Can J Physiol Pharmacol. 2015;93:385-394. [PMID: 25894394 DOI: 10.1139/cjpp-2014-0275] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
16 Seo JA, Eun CR, Cho H, Lee SK, Yoo HJ, Kim SG, Choi KM, Baik SH, Choi DS, Yim HJ, Shin C, Kim NH. Low vitamin D status is associated with nonalcoholic Fatty liver disease independent of visceral obesity in Korean adults. PLoS One 2013;8:e75197. [PMID: 24130687 DOI: 10.1371/journal.pone.0075197] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
17 Jiang F, Yang Y, Xue L, Li B, Zhang Z. 1α,25-dihydroxyvitamin D3 Attenuates TGF-β-Induced Pro-Fibrotic Effects in Human Lung Epithelial Cells through Inhibition of Epithelial-Mesenchymal Transition. Nutrients 2017;9:E980. [PMID: 28878195 DOI: 10.3390/nu9090980] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
18 Grünhage F, Hochrath K, Krawczyk M, Höblinger A, Obermayer-Pietsch B, Geisel J, Trauner M, Sauerbruch T, Lammert F. Common genetic variation in vitamin D metabolism is associated with liver stiffness. Hepatology 2012;56:1883-91. [PMID: 22576297 DOI: 10.1002/hep.25830] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
19 Wu DB, Wang ML, Chen EQ, Tang H. New insights into the role of vitamin D in hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol 2018;12:287-94. [PMID: 29140126 DOI: 10.1080/17474124.2018.1406307] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
20 Kempinska-Podhorodecka A, Milkiewicz M, Jabłonski D, Milkiewicz P, Wunsch E. ApaI polymorphism of vitamin D receptor affects health-related quality of life in patients with primary sclerosing cholangitis. PLoS One 2017;12:e0176264. [PMID: 28426778 DOI: 10.1371/journal.pone.0176264] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
21 Sriphoosanaphan S, Thanapirom K, Suksawatamnuay S, Thaimai P, Sittisomwong S, Sonsiri K, Srisoonthorn N, Teeratorn N, Tanpowpong N, Chaopathomkul B, Treeprasertsuk S, Poovorawan Y, Komolmit P. Changes in hepatic fibrosis and vitamin D levels after viral hepatitis C eradication using direct-acting antiviral therapy. BMC Gastroenterol 2020;20:346. [PMID: 33069226 DOI: 10.1186/s12876-020-01485-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Kim HB, Myung SK, Lee YJ, Park BJ. Efficacy of vitamin D supplementation in combination with conventional antiviral therapy in patients with chronic hepatitis C infection: a meta-analysis of randomised controlled trials. J Hum Nutr Diet. 2017; Epub ahead of print. [PMID: 28833855 DOI: 10.1111/jhn.12503] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
23 Rau M, Baur K, Geier A. Host genetic variants in the pathogenesis of hepatitis C. Viruses 2012;4:3281-302. [PMID: 23342360 DOI: 10.3390/v4123281] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
24 Lee P, Yang Y, Lee W, Lee K, Hsieh Y, Lee T, Lin H. Comparative portal hypotensive effects as propranolol of vitamin D 3 treatment by decreasing intrahepatic resistance in cirrhotic rats: Portal hypotensive effects of vitamin D 3. J Gastroenterol Hepatol 2015;30:628-37. [DOI: 10.1111/jgh.12721] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
25 Lai M, Afdhal NH. Clinical utility of interleukin-28B testing in patients with genotype 1. Hepatology 2012;56:367-72. [PMID: 22511388 DOI: 10.1002/hep.25793] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
26 Bräu N. Evaluation of the hepatitis C virus-infected patient: the initial encounter. Clin Infect Dis. 2013;56:853-860. [PMID: 23243172 DOI: 10.1093/cid/cis957] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
27 Abramovitch S, Sharvit E, Weisman Y, Bentov A, Brazowski E, Cohen G, Volovelsky O, Reif S. Vitamin D inhibits development of liver fibrosis in an animal model but cannot ameliorate established cirrhosis. Am J Physiol Gastrointest Liver Physiol 2015;308:G112-20. [PMID: 25214398 DOI: 10.1152/ajpgi.00132.2013] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 5.9] [Reference Citation Analysis]
28 Kubesch A, Quenstedt L, Saleh M, Rüschenbaum S, Schwarzkopf K, Martinez Y, Welsch C, Zeuzem S, Welzel TM, Lange CM. Vitamin D deficiency is associated with hepatic decompensation and inflammation in patients with liver cirrhosis: A prospective cohort study. PLoS One 2018;13:e0207162. [PMID: 30408125 DOI: 10.1371/journal.pone.0207162] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
29 Myers RP, Ramji A, Bilodeau M, Wong S, Feld JJ. An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver. Can J Gastroenterol 2012;26:359-75. [PMID: 22720279 DOI: 10.1155/2012/947676] [Cited by in Crossref: 40] [Cited by in F6Publishing: 54] [Article Influence: 4.0] [Reference Citation Analysis]
30 Hansson L, Sandberg C, Öhlund I, Lind T, Sthen Bergdahl M, Wiklund U, Rylander Hedlund E, Sjöberg G, Rydberg A. Vitamin D, liver-related biomarkers, and distribution of fat and lean mass in young patients with Fontan circulation. Cardiol Young 2021;:1-8. [PMID: 34338624 DOI: 10.1017/S1047951121003115] [Reference Citation Analysis]
31 Saber A, Fotuhi F, Rostami Z, Einollahi B, Nemati E. Vitamin D Levels After Kidney Transplantation and the Risk of Cytomegalovirus Infection. Nephrourol Mon 2015;7:e29677. [PMID: 26866004 DOI: 10.5812/numonthly.29677] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
32 Moosavy SH, Davoodian P, Nazarnezhad MA, Nejatizaheh A, Eftekhar E, Mahboobi H. Epidemiology, transmission, diagnosis, and outcome of Hepatitis C virus infection. Electron Physician 2017;9:5646-56. [PMID: 29238510 DOI: 10.19082/5646] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
33 Lin LY, Bhate K, Forbes H, Smeeth L, Warren-Gash C, Langan S. Vitamin D deficiency or supplementation and the risk of human herpesvirus infections or reactivation: a systematic review protocol. BMJ Open 2019;9:e031867. [PMID: 31594899 DOI: 10.1136/bmjopen-2019-031867] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Thanapirom K, Suksawatamnuay S, Sukeepaisarnjaroen W, Tangkijvanich P, Thaimai P, Wasitthankasem R, Poovorawan Y, Komolmit P. Genetic associations of vitamin D receptor polymorphisms with advanced liver fibrosis and response to pegylated interferon-based therapy in chronic hepatitis C. PeerJ 2019;7:e7666. [PMID: 31565578 DOI: 10.7717/peerj.7666] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
35 Nasiroglu Imga N, Efe C. Editorial: the role of vitamin D in autoimmune hepatitis. Aliment Pharmacol Ther 2019;49:342-3. [DOI: 10.1111/apt.15075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
36 Palmer LB, Kuftinec G, Pearlman M, Green CH. Nutrition in Cirrhosis. Curr Gastroenterol Rep. 2019;21:38. [PMID: 31289936 DOI: 10.1007/s11894-019-0706-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
37 Atsukawa M, Tsubota A, Shimada N, Kondo C, Itokawa N, Nakagawa A, Hashimoto S, Fukuda T, Matsushita Y, Narahara Y, Iwakiri K, Nakatsuka K, Kawamoto C, Sakamoto C. Serum 25-hydroxyvitamin D 3 levels affect treatment outcome in pegylated interferon/ribavirin combination therapy for compensated cirrhotic patients with hepatitis C virus genotype 1b and high viral load: Vitamin D 3 and cirrhosis treatment outcome. Hepatol Res 2014;44:1277-85. [DOI: 10.1111/hepr.12298] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
38 Cianferotti L, Cricelli C, Kanis JA, Nuti R, Reginster JY, Ringe JD, Rizzoli R, Brandi ML. The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF). Endocrine 2015;50:12-26. [PMID: 25931412 DOI: 10.1007/s12020-015-0606-x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 4.9] [Reference Citation Analysis]
39 Coelho HSM, Villela-nogueira CA. Predictors of response to chronic hepatitis C treatment. Annals of Hepatology 2010;9:S54-60. [DOI: 10.1016/s1665-2681(19)31725-9] [Cited by in Crossref: 10] [Article Influence: 0.8] [Reference Citation Analysis]
40 Strasser SI, Vidot H. Nutritional considerations in end-stage liver disease. J Gastroenterol Hepatol 2011;26:1346-8. [PMID: 21884244 DOI: 10.1111/j.1440-1746.2011.06830.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
41 Farnik H, Bojunga J, Berger A, Allwinn R, Waidmann O, Kronenberger B, Keppler OT, Zeuzem S, Sarrazin C, Lange CM. Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients. Hepatology 2013;58:1270-6. [PMID: 23703797 DOI: 10.1002/hep.26488] [Cited by in Crossref: 88] [Cited by in F6Publishing: 87] [Article Influence: 9.8] [Reference Citation Analysis]
42 Singh A, Falk MK, Subhi Y, Sørensen TL. The association between plasma 25-hydroxyvitamin D and subgroups in age-related macular degeneration: a cross-sectional study. PLoS One 2013;8:e70948. [PMID: 23923033 DOI: 10.1371/journal.pone.0070948] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
43 Berger CT, Kim AY. IL28B polymorphisms as a pretreatment predictor of response to HCV treatment. Infect Dis Clin North Am 2012;26:863-77. [PMID: 23083820 DOI: 10.1016/j.idc.2012.08.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
44 Kanda T, Imazeki F, Yokosuka O. New antiviral therapies for chronic hepatitis C. Hepatol Int. 2010;4:548-561. [PMID: 21063477 DOI: 10.1007/s12072-010-9193-3] [Cited by in Crossref: 79] [Cited by in F6Publishing: 96] [Article Influence: 6.6] [Reference Citation Analysis]
45 Colombo M, Sangiovanni A. Vitamin D deficiency and liver cancer: more than just an epidemiological association? Hepatology 2014;60:1130-2. [PMID: 24752901 DOI: 10.1002/hep.27178] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
46 Chen CY, Wang BT, Wu ZC, Yu WT, Lin PJ, Tsai WL, Shiesh SC. Glycine ameliorates liver injury and vitamin D deficiency induced by bile duct ligation. Clin Chim Acta 2013;420:150-4. [PMID: 23103539 DOI: 10.1016/j.cca.2012.10.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
47 Nimer A, Mouch A. Vitamin D improves viral response in hepatitis C genotype 2-3 naïve patients. World J Gastroenterol 2012; 18(8): 800-805 [PMID: 22371640 DOI: 10.3748/wjg.v18.i8.800] [Cited by in CrossRef: 99] [Cited by in F6Publishing: 99] [Article Influence: 9.9] [Reference Citation Analysis]
48 Chen EQ, Shi Y, Tang H. New insight of vitamin D in chronic liver diseases. Hepatobiliary Pancreat Dis Int 2014;13:580-5. [PMID: 25475859 DOI: 10.1016/s1499-3872(14)60295-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
49 Iruzubieta P, Terán &, Crespo J, Fábrega E. Vitamin D deficiency in chronic liver disease. World J Hepatol 2014; 6(12): 901-915 [PMID: 25544877 DOI: 10.4254/wjh.v6.i12.901] [Cited by in Crossref: 61] [Cited by in F6Publishing: 50] [Article Influence: 7.6] [Reference Citation Analysis]
50 Barchetta I, Angelico F, Del Ben M, Baroni MG, Pozzilli P, Morini S, Cavallo MG. Strong association between nonalcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med. 2011;9:85. [PMID: 21749681 DOI: 10.1186/1741-7015-9-85] [Cited by in Crossref: 187] [Cited by in F6Publishing: 169] [Article Influence: 17.0] [Reference Citation Analysis]
51 Komolmit P, Charoensuk K, Thanapirom K, Suksawatamnuay S, Thaimai P, Chirathaworn C, Poovorawan Y. Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: A randomised double-blinded, placebo-control trial. PLoS One 2017;12:e0174608. [PMID: 28376103 DOI: 10.1371/journal.pone.0174608] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
52 Abdel-Ghaffar TY, Behairy EB, Abd El-Shaheed A, Mahdy K, El-Batanony M, Hussein MH, Sira MM. Clinical Benefits of Biochemical Markers of Fibrosis in Egyptian Children With Chronic Liver Diseases. Gastroenterol Res. 2010;3:262-271. [PMID: 27942306 DOI: 10.4021/gr246w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
53 Berry L, Irving W. Predictors of hepatitis C treatment response: what's new? Expert Rev Anti Infect Ther 2014;12:183-91. [PMID: 24404996 DOI: 10.1586/14787210.2014.874283] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
54 Mohamed AA, Abd Almonaem ER, Mansour AI, Algebaly HF, Khattab RA, El Abd YS. Importance of Studying the Levels of Hepcidin and Vitamin D in Egyptian Children with Chronic Hepatitis C. J Transl Int Med 2019;7:15-21. [PMID: 30997352 DOI: 10.2478/jtim-2019-0004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
55 Zhu Q, Li N, Han Q, Li Z, Zhang G, Li F, Zhang P, Chen J, Lv Y, Liu Z. Single-nucleotide polymorphism at CYP27B1-1260, but not VDR Taq I, is possibly associated with persistent hepatitis B virus infection. Genet Test Mol Biomarkers 2012;16:1115-21. [PMID: 22963605 DOI: 10.1089/gtmb.2012.0148] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
56 Fan HZ, Zhang R, Tian T, Zhong YL, Wu MP, Xie CN, Yang JJ, Huang P, Yu RB, Zhang Y, Wang J. CYP24A1 genetic variants in the vitamin D metabolic pathway are involved in the outcomes of hepatitis C virus infection among high-risk Chinese population. Int J Infect Dis 2019;84:80-8. [PMID: 31075507 DOI: 10.1016/j.ijid.2019.04.032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
57 Chiu KW, Nakano T, Hu TH, Chen KD, Hsu LW, Eng HL, Cheng YF, Goto S, Chen CL. Association between Subclinical Low Serum 25(OH)D in Donors and Fatty Liver Disease in Recipients after Living Donor Liver Transplantation. Biomed Res Int 2018;2018:4508085. [PMID: 29750155 DOI: 10.1155/2018/4508085] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
58 Zhang Y, Jiang X, Li X, Găman MA, Kord-Varkaneh H, Rahmani J, Salehi-Sahlabadi A, Day AS, Xu Y. Serum Vitamin D Levels and Risk of Liver Cancer: A Systematic Review and Dose-Response Meta-Analysis of Cohort Studies. Nutr Cancer 2021;73:1-9. [PMID: 32705896 DOI: 10.1080/01635581.2020.1797127] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
59 Bitetto D, Fabris C, Falleti E, Toniutto P. Vitamin D deficiency and HCV chronic infection: what comes first? J Hepatol 2011;55:944-5; author reply 945. [PMID: 21349298 DOI: 10.1016/j.jhep.2011.01.044] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
60 Russo S, Carlucci L, Cipriani C, Ragno A, Piemonte S, Fiacco RD, Pepe J, Fassino V, Arima S, Romagnoli E, Minisola S. Metabolic Changes Following 500 μg Monthly Administration of Calcidiol: A Study in Normal Females. Calcif Tissue Int 2011;89:252-7. [DOI: 10.1007/s00223-011-9513-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
61 Reda R, Abbas AA, Mohammed M, El Fedawy SF, Ghareeb H, El Kabarity RH, Abo-Shady RA, Zakaria D. The Interplay between Zinc, Vitamin D and, IL-17 in Patients with Chronic Hepatitis C Liver Disease. J Immunol Res. 2015;2015:846348. [PMID: 26504859 DOI: 10.1155/2015/846348] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
62 Keane JT, Elangovan H, Stokes RA, Gunton JE. Vitamin D and the Liver-Correlation or Cause? Nutrients 2018;10:E496. [PMID: 29659559 DOI: 10.3390/nu10040496] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 9.3] [Reference Citation Analysis]
63 Kitson MT, Sarrazin C, Toniutto P, Eslick GD, Roberts SK. Vitamin D level and sustained virologic response to interferon-based antiviral therapy in chronic hepatitis C: a systematic review and meta-analysis. J Hepatol. 2014;61:1247-1252. [PMID: 25135863 DOI: 10.1016/j.jhep.2014.08.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
64 Gayam V, Mandal AK, Khalid M, Mukhtar O, Gill A, Garlapati P, Tiongson B, Sherigar J, Mansour M, Mohanty S. Association Between Vitamin D Levels and Treatment Response to Direct-Acting Antivirals in Chronic Hepatitis C: A Real-World Study. Gastroenterology Res 2018;11:309-16. [PMID: 30116431 DOI: 10.14740/gr1072w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
65 Fotiadis K, Filidou E, Arvanitidis K, Valatas V, Stavrou G, Basdanis G, Paspaliaris V, Kolios G, Kotzampassi K. Intraperitoneal application of phospholipids for the prevention of postoperative adhesions: a possible role of myofibroblasts. Journal of Surgical Research 2015;197:291-300. [DOI: 10.1016/j.jss.2015.04.036] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
66 Khoo AL, Chai L, Koenen H, Joosten I, Netea M, van der Ven A. Translating the role of vitamin D3 in infectious diseases. Crit Rev Microbiol 2012;38:122-35. [PMID: 22304022 DOI: 10.3109/1040841X.2011.622716] [Cited by in Crossref: 51] [Cited by in F6Publishing: 18] [Article Influence: 5.1] [Reference Citation Analysis]
67 Backstedt D, Pedersen M, Choi M, Seetharam A. 25-Vitamin D levels in chronic hepatitis C infection: association with cirrhosis and sustained virologic response. Ann Gastroenterol. 2017;30:344-348. [PMID: 28469365 DOI: 10.20524/aog.2017.0120] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
68 Cañamares-Orbis P, Bernal-Monterde V, Sierra-Gabarda O, Casas-Deza D, Garcia-Rayado G, Cortes L, Lué A. Impact of Liver and Pancreas Diseases on Nutritional Status. Nutrients 2021;13:1650. [PMID: 34068295 DOI: 10.3390/nu13051650] [Reference Citation Analysis]
69 Bjelakovic M, Nikolova D, Bjelakovic G, Gluud C. Vitamin D supplementation for chronic liver diseases in adults. Cochrane Database Syst Rev 2021;8:CD011564. [PMID: 34431511 DOI: 10.1002/14651858.CD011564.pub3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Amanzada A, Goralczyk AD, Moriconi F, van Thiel DH, Ramadori G, Mihm S. Vitamin D status and serum ferritin concentration in chronic hepatitis C virus type 1 infection. J Med Virol. 2013;85:1534-1541. [PMID: 23852677 DOI: 10.1002/jmv.23632] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
71 Frias M, Rivero-Juárez A, López-López P, Rivero A. Pharmacogenetics and the treatment of HIV-/HCV-coinfected patients. Pharmacogenomics 2018;19:979-95. [PMID: 29992850 DOI: 10.2217/pgs-2018-0046] [Reference Citation Analysis]
72 Grünhage F, Mahler M, Reichel C, Lammert F. Extremely low vitamin d levels are associated with increased mortality in patients with liver cirrhosis. J Hepatol. 2012;56:S247. [PMID: 24236541 DOI: 10.1111/eci.12205] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
73 Beilfuss A, Sowa JP, Sydor S, Beste M, Bechmann LP, Schlattjan M, Syn WK, Wedemeyer I, Mathé Z, Jochum C, Gerken G, Gieseler RK, Canbay A. Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently. Gut 2015;64:791-9. [PMID: 25134788 DOI: 10.1136/gutjnl-2014-307024] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 11.6] [Reference Citation Analysis]
74 Mou H, Yang F, Zhou J, Bao C. Correlation of liver function with intestinal flora, vitamin deficiency and IL-17A in patients with liver cirrhosis. Exp Ther Med 2018;16:4082-8. [PMID: 30344685 DOI: 10.3892/etm.2018.6663] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
75 Himoto T, Masaki T. Associations between Zinc Deficiency and Metabolic Abnormalities in Patients with Chronic Liver Disease. Nutrients. 2018;10. [PMID: 29342898 DOI: 10.3390/nu10010088] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 14.0] [Reference Citation Analysis]
76 Sari E, Oztay F, Tasci AE. Vitamin D modulates E-cadherin turnover by regulating TGF-β and Wnt signalings during EMT-mediated myofibroblast differentiation in A459 cells. J Steroid Biochem Mol Biol 2020;202:105723. [PMID: 32603782 DOI: 10.1016/j.jsbmb.2020.105723] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
77 Lambert AA, Drummond MB, Mehta SH, Brown TT, Lucas GM, Kirk GD, Estrella MM. Risk factors for vitamin D deficiency among HIV-infected and uninfected injection drug users. PLoS One 2014;9:e95802. [PMID: 24756000 DOI: 10.1371/journal.pone.0095802] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
78 Ko BJ, Kim YS, Kim SG, Park JH, Lee SH, Jeong SW, Jang JY, Kim HS, Kim BS, Kim SM. Relationship between 25-Hydroxyvitamin D Levels and Liver Fibrosis as Assessed by Transient Elastography in Patients with Chronic Liver Disease. Gut Liver. 2016;10:818-825. [PMID: 27114415 DOI: 10.5009/gnl15331] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
79 Ladero JM, Torrejón MJ, Sánchez-pobre P, Suárez A, Cuenca F, de la Orden V, Devesa MJ, Rodrigo M, Estrada V, López-alonso G, Agúndez JA. Vitamin D deficiency and vitamin D therapy in chronic hepatitis C. Annals of Hepatology 2013;12:199-204. [DOI: 10.1016/s1665-2681(19)31357-2] [Cited by in Crossref: 30] [Article Influence: 3.3] [Reference Citation Analysis]
80 Soriano V, Sherman KE, Rockstroh J, Dieterich D, Back D, Sulkowski M, Peters M. Challenges and opportunities for hepatitis C drug development in HIV-hepatitis C virus-co-infected patients. AIDS 2011;25:2197-208. [PMID: 21866039 DOI: 10.1097/QAD.0b013e32834bbb90] [Cited by in Crossref: 29] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
81 Scalioni LP, Santos BRD, Spritzer PM, Villela-Nogueira CA, Laura Lewis-Ximenez L, Pollo-Flores P, Bordalo Cathalá Esberard E, Brandão-Mello CE, Lampe E, Villar LM. Impact of vitamin D receptor and binding protein gene polymorphisms in clinical and laboratory data of HCV patients: Cross sectional study. Medicine (Baltimore) 2018;97:e9881. [PMID: 29465575 DOI: 10.1097/MD.0000000000009881] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
82 Gürbüz F, Ağın M, Mengen E, Elçi H, Ünal İ, Tümgör G, Yüksel B. Kronik karaciğer hastalığı olan çocukların D vitamini düzeyleri. Cukurova Medical Journal 2018;43:1-1. [DOI: 10.17826/cumj.365057] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
83 Aly WW, Hussein MA, Moahamed Ebeid S, Mortagy AK. Prevalence of vitamin D insufficiency among community dwelling elderly in Dakahlia as a representative of rural areas in Egypt. Aging Clin Exp Res 2014;26:47-51. [PMID: 24129804 DOI: 10.1007/s40520-013-0139-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
84 Li YF, Tang XL, Ling WH. 1,25-dihydroxyvitamin D3 inhibits fibrosis in mice with NAFLD induced by a methionine-choline-deficient diet. Shijie Huaren Xiaohua Zazhi 2012; 20(33): 3191-3196 [DOI: 10.11569/wcjd.v20.i33.3191] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
85 Murayama A, Kato T. Inhibition of hepatitis C virus by vitamin D. Vitam Horm 2021;117:227-38. [PMID: 34420582 DOI: 10.1016/bs.vh.2021.06.006] [Reference Citation Analysis]
86 Abu-Mouch S, Fireman Z, Jarchovsky J, Zeina AR, Assy N. Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients. World J Gastroenterol 2011; 17(47): 5184-5190 [PMID: 22215943 DOI: 10.3748/wjg.v17.i47.5184] [Cited by in CrossRef: 148] [Cited by in F6Publishing: 140] [Article Influence: 13.5] [Reference Citation Analysis]
87 Anty R, Canivet CM, Patouraux S, Ferrari-Panaia P, Saint-Paul MC, Huet PM, Lebeaupin C, Iannelli A, Gual P, Tran A. Severe Vitamin D Deficiency May be an Additional Cofactor for the Occurrence of Alcoholic Steatohepatitis. Alcohol Clin Exp Res. 2015;39:1027-1033. [PMID: 25941109 DOI: 10.1111/acer.12728] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
88 García-Álvarez M, Pineda-Tenor D, Jiménez-Sousa MA, Fernández-Rodríguez A, Guzmán-Fulgencio M, Resino S. Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: a meta-analysis. Hepatology 2014;60:1541-50. [PMID: 24975775 DOI: 10.1002/hep.27281] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 7.0] [Reference Citation Analysis]
89 Mohammed MA, Omar NM, Mansour AH, Abd El-azi SM, Othman G. 25-Hydroxyvitamin D3 Level in Patients with Chronic Viral Hepatitis B. J of Medical Sciences 2014;14:192-200. [DOI: 10.3923/jms.2014.192.200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
90 Barooah P, Saikia S, Bharadwaj R, Sarmah P, Bhattacharyya M, Goswami B, Medhi S. Role of VDR, GC, and CYP2R1 Polymorphisms in the Development of Hepatocellular Carcinoma in Hepatitis C Virus-Infected Patients. Genet Test Mol Biomarkers 2019;23:325-31. [PMID: 30942619 DOI: 10.1089/gtmb.2018.0170] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
91 Yin P, Xie S, Zhuang Z, He X, Tang X, Tian L, Liu Y, Niu J. Dietary supplementation of bile acid attenuate adverse effects of high-fat diet on growth performance, antioxidant ability, lipid accumulation and intestinal health in juvenile largemouth bass (Micropterus salmoides). Aquaculture 2021;531:735864. [DOI: 10.1016/j.aquaculture.2020.735864] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 12.0] [Reference Citation Analysis]
92 Jha AK, Jha SK, Kumar A, Dayal VM, Jha SK. Effect of replenishment of vitamin D on survival in patients with decompensated liver cirrhosis: A prospective study. World J Gastrointest Pathophysiol 2017; 8(3): 133-141 [PMID: 28868183 DOI: 10.4291/wjgp.v8.i3.133] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
93 Kong M, Zhu L, Bai L, Zhang X, Chen Y, Liu S, Zheng S, Pandol SJ, Han YP, Duan Z. Vitamin D deficiency promotes nonalcoholic steatohepatitis through impaired enterohepatic circulation in animal model. Am J Physiol Gastrointest Liver Physiol. 2014;307:G883-G893. [PMID: 25214402 DOI: 10.1152/ajpgi.00427.2013] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
94 Hammad LN, Abdelraouf SM, Hassanein FS, Mohamed WA, Schaalan MF. Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: potential biomarkers for a more favorable prognosis? J Immunotoxicol. 2013;10:380-386. [PMID: 23350952 DOI: 10.3109/1547691x.2012.758198] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
95 Atsukawa M, Tsubota A, Shimada N, Yoshizawa K, Abe H, Asano T, Ohkubo Y, Araki M, Ikegami T, Okubo T, Kondo C, Osada Y, Nakatsuka K, Chuganji Y, Matsuzaki Y, Iwakiri K, Aizawa Y. Effect of native vitamin D 3 supplementation on refractory chronic hepatitis C patients in simeprevir with pegylated interferon/ribavirin: Effect of vitamin D in simeprevir triple therapy. Hepatol Res 2016;46:450-8. [DOI: 10.1111/hepr.12575] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
96 Gal-Tanamy M, Bachmetov L, Ravid A, Koren R, Erman A, Tur-Kaspa R, Zemel R. Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes. Hepatology 2011;54:1570-9. [PMID: 21793032 DOI: 10.1002/hep.24575] [Cited by in Crossref: 119] [Cited by in F6Publishing: 125] [Article Influence: 10.8] [Reference Citation Analysis]
97 Saleh M, Welsch C, Cai C, Döring C, Gouttenoire J, Friedrich J, Haselow K, Sarrazin C, Badenhoop K, Moradpour D, Zeuzem S, Rueschenbaum S, Lange CM. Differential modulation of hepatitis C virus replication and innate immune pathways by synthetic calcitriol-analogs. J Steroid Biochem Mol Biol 2018;183:142-51. [PMID: 29885880 DOI: 10.1016/j.jsbmb.2018.06.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
98 Weintraub SJ, Fleckenstein JF, Marion TN, Madey MA, Mahmoudi TM, Schechtman KB. Vitamin D and the racial difference in the genotype 1 chronic hepatitis C treatment response. Am J Clin Nutr 2012;96:1025-31. [PMID: 23015322 DOI: 10.3945/ajcn.112.039974] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
99 Wu P, Zhang R, Luo M, Zhang T, Pan L, Xu S, Pan L, Ren F, Ji C, Hu R, Noureddin M, Pandol SJ, Han YP. Liver Injury Impaired 25-Hydroxylation of Vitamin D Suppresses Intestinal Paneth Cell defensins, leading to Gut Dysbiosis and Liver Fibrogenesis. Am J Physiol Gastrointest Liver Physiol 2020. [PMID: 33084400 DOI: 10.1152/ajpgi.00021.2020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
100 Lange CM, Zeuzem S. IL28B single nucleotide polymorphisms in the treatment of hepatitis C. J Hepatol 2011;55:692-701. [PMID: 21440591 DOI: 10.1016/j.jhep.2011.03.006] [Cited by in Crossref: 75] [Cited by in F6Publishing: 77] [Article Influence: 6.8] [Reference Citation Analysis]
101 Vosoghinia H, Esmaeilzadeh A, Ganji A, Hosseini SM, Jamehdar SA, Salehi M, Bahari A, Ghanaei O, Sahebari M, Rajabzadeh F, Ghaffarzadehgan K, Goshayeshi L. Vitamin D in Standard HCV Regimen (PEG-Interferon Plus Ribavirin), Its Effect on the Early Virologic Response Rate: A Clinical Trial. Razavi Int J Med 2016;4. [DOI: 10.17795/rijm36632] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
102 Finkelmeier F, Kronenberger B, Köberle V, Bojunga J, Zeuzem S, Trojan J, Piiper A, Waidmann O. Severe 25-hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma - a prospective cohort study. Aliment Pharmacol Ther 2014;39:1204-12. [DOI: 10.1111/apt.12731] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 6.8] [Reference Citation Analysis]
103 Avihingsanon A, Jitmitraparp S, Tangkijvanich P, Ramautarsing RA, Apornpong T, Jirajariyavej S, Putcharoen O, Treeprasertsuk S, Akkarathamrongsin S, Poovorawan Y. Advanced liver fibrosis by transient elastography, fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: role of vitamin D levels. J Gastroenterol Hepatol. 2014;29:1706-1714. [PMID: 24730732 DOI: 10.1111/jgh.12613] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
104 Trépo E, Ouziel R, Pradat P, Momozawa Y, Quertinmont E, Gervy C, Gustot T, Degré D, Vercruysse V, Deltenre P, Verset L, Gulbis B, Franchimont D, Devière J, Lemmers A, Moreno C. Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease. Journal of Hepatology 2013;59:344-50. [DOI: 10.1016/j.jhep.2013.03.024] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 7.8] [Reference Citation Analysis]
105 Chiu KW, Goto S, Nakano T, Hu TH, Chen DW, Huang KT, Hsu LW, Chen CL. Genetic polymorphisms of the hepatic pathways of fatty liver disease after living donor liver transplantation. Liver Int 2018;38:2287-93. [PMID: 29935100 DOI: 10.1111/liv.13920] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
106 Gençosmanoğlu Türkmen G, Vural Yilmaz Z, Dağlar K, Kara Ö, Sanhal CY, Yücel A, Uygur D. Low serum vitamin D level is associated with intrahepatic cholestasis of pregnancy: Serum Vit D level in intrahepatic cholestasis of pregnancy. J Obstet Gynaecol Res 2018;44:1712-8. [DOI: 10.1111/jog.13693] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
107 Behera MK, Shukla SK, Dixit VK, Nath P, Abhilash VB, Asati PK, Jain AK. Effect of vitamin D supplementation on sustained virological response in genotype 1/4 chronic hepatitis C treatment-naïve patients from India. Indian J Med Res 2018;148:200-6. [PMID: 30381543 DOI: 10.4103/ijmr.IJMR_1295_15] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
108 Petta S, Marchesini G, Caracausi L, Macaluso FS, Cammà C, Ciminnisi S, Cabibi D, Porcasi R, Craxì A, Di Marco V. Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients. J Hepatol 2013;59:1169-76. [PMID: 23933265 DOI: 10.1016/j.jhep.2013.07.037] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
109 Hung CH, Hu TH, Lu SN, Chen CH, Wang JH, Lee CM. Association of vitamin D receptor gene polymorphisms with response to peginterferon plus ribavirin in Asian patients with chronic hepatitis C. J Formos Med Assoc 2016;115:278-83. [PMID: 26725771 DOI: 10.1016/j.jfma.2015.11.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
110 Baur K, Mertens JC, Schmitt J, Iwata R, Stieger B, Eloranta JJ, Frei P, Stickel F, Dill MT, Seifert B, Ferrari HA, von Eckardstein A, Bochud PY, Müllhaupt B, Geier A; Swiss Hepatitis C Cohort Study Group. Combined effect of 25-OH vitamin D plasma levels and genetic vitamin D receptor (NR 1I1) variants on fibrosis progression rate in HCV patients. Liver Int 2012;32:635-43. [PMID: 22151003 DOI: 10.1111/j.1478-3231.2011.02674.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 6.3] [Reference Citation Analysis]
111 Wang JJ, Gu JY, Jiang HM, Hu CH. Influence of vitamin D3 on ultramicrostructural changes of hepatic tissue in rats with experimental hepatic injury. Shijie Huaren Xiaohua Zazhi 2015; 23(6): 885-893 [DOI: 10.11569/wcjd.v23.i6.885] [Reference Citation Analysis]
112 El Husseiny NM, Fahmy HM, Mohamed WA, Amin HH. Relationship between vitamin D and IL-23, IL-17 and macrophage chemoattractant protein-1 as markers of fibrosis in hepatitis C virus Egyptians. World J Hepatol 2012; 4(8): 242-247 [PMID: 22993666 DOI: 10.4254/wjh.v4.i8.242] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
113 Abdelsalam A, Rashed L, Salman T, Hammad L, Sabry D. Molecular assessment of vitamin D receptor polymorphism as a valid predictor to the response of interferon/ribavirin-based therapy in Egyptian patients with chronic hepatitis C. J Dig Dis 2016;17:547-53. [PMID: 27128845 DOI: 10.1111/1751-2980.12353] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
114 Rahman AH, Branch AD. Vitamin D for your patients with chronic hepatitis C? J Hepatol. 2013;58:184-189. [PMID: 22871501 DOI: 10.1016/j.jhep.2012.07.026] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
115 Itokawa N, Atsukawa M, Tsubota A, Abe H, Shimada N, Okubo T, Arai T, Nakagawa A, Kondo C, Aizawa Y, Iwakiri K. The Relationship Between 25-Hydroxyvitamin D3 and Hepatitis B Surface Antigen Levels in Patients with Chronic Hepatitis B in Japan. Hepat Mon 2018;18. [DOI: 10.5812/hepatmon.63587] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
116 Wang H, Chen W, Li D, Yin X, Zhang X, Olsen N, Zheng SG. Vitamin D and Chronic Diseases. Aging Dis 2017;8:346-53. [PMID: 28580189 DOI: 10.14336/AD.2016.1021] [Cited by in Crossref: 109] [Cited by in F6Publishing: 63] [Article Influence: 21.8] [Reference Citation Analysis]
117 Zhao XY, Li J, Wang JH, Habib S, Wei W, Sun SJ, Strobel HW, Jia JD. Vitamin D serum level is associated with Child-Pugh score and metabolic enzyme imbalances, but not viral load in chronic hepatitis B patients. Medicine (Baltimore). 2016;95:e3926. [PMID: 27399065 DOI: 10.1097/md.0000000000003926] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
118 Falleti E, Bitetto D, Fabris C, Fattovich G, Cussigh A, Cmet S, Ceriani E, Fornasiere E, Pasino M, Ieluzzi D, Pirisi M, Toniutto P. Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C. Hepatology 2012;56:1641-50. [PMID: 22610885 DOI: 10.1002/hep.25848] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
119 Samra NM, Emad El Abrak S, El Dash HH, El Said El Raziky M, El Sheikh MA. Evaluation of vitamin D status bone mineral density and dental health in children with cholestasis. Clinics and Research in Hepatology and Gastroenterology 2018;42:368-77. [DOI: 10.1016/j.clinre.2017.11.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
120 Hochrath K, Stokes CS, Geisel J, Pollheimer MJ, Fickert P, Dooley S, Lammert F. Vitamin D modulates biliary fibrosis in ABCB4-deficient mice. Hepatol Int 2014;8:443-52. [PMID: 25191532 DOI: 10.1007/s12072-014-9548-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
121 Skaaby T, Husemoen LL, Borglykke A, Jørgensen T, Thuesen BH, Pisinger C, Schmidt LE, Linneberg A. Vitamin D status, liver enzymes, and incident liver disease and mortality: a general population study. Endocrine 2014;47:213-20. [PMID: 24272594 DOI: 10.1007/s12020-013-0107-8] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
122 Kitson MT, Dore GJ, George J, Button P, McCaughan GW, Crawford DH, Sievert W, Weltman MD, Cheng WS, Roberts SK. Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection. J Hepatol. 2013;58:467-472. [PMID: 23183524 DOI: 10.1016/j.jhep.2013.02.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
123 Guo GY, Shi YQ, Wang L, Ren X, Han ZY, Guo CC, Cui LN, Wang JB, Zhu J, Wang N. Serum vitamin D level is associated with disease severity and response to ursodeoxycholic acid in primary biliary cirrhosis. Aliment Pharmacol Ther. 2015;42:221-230. [PMID: 25982180 DOI: 10.1111/apt.13244] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
124 Dasarathy J, Periyalwar P, Allampati S, Bhinder V, Hawkins C, Brandt P, Khiyami A, McCullough AJ, Dasarathy S. Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease. Liver Int. 2014;34:e118-e127. [PMID: 24118743 DOI: 10.1111/liv.12312] [Cited by in Crossref: 70] [Cited by in F6Publishing: 70] [Article Influence: 7.8] [Reference Citation Analysis]
125 Mayr U, Fahrenkrog-Petersen L, Batres-Baires G, Rasch S, Herner A, Schmid RM, Huber W, Lahmer T. Vitamin D Deficiency Is Highly Prevalent in Critically Ill Patients and a Risk Factor for Mortality: A Prospective Observational Study Comparing Noncirrhotic Patients and Patients With Cirrhosis. J Intensive Care Med 2020;35:992-1001. [PMID: 30270710 DOI: 10.1177/0885066618803844] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
126 Atsukawa M, Tsubota A, Shimada N, Abe H, Kondo C, Itokawa N, Nakagawa A, Iwakiri K, Kawamoto C, Aizawa Y. Serum 25(OH)D3 levels affect treatment outcomes for telaprevir/peg-interferon/ribavirin combination therapy in genotype 1b chronic hepatitis C. Dig Liver Dis. 2014;46:738-743. [PMID: 24880716 DOI: 10.1016/j.dld.2014.05.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
127 Schwalfenberg GK. A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Mol Nutr Food Res. 2011;55:96-108. [PMID: 20824663 DOI: 10.1002/mnfr.201000174] [Cited by in Crossref: 186] [Cited by in F6Publishing: 166] [Article Influence: 15.5] [Reference Citation Analysis]
128 Germani G, Tsochatzis E, Papastergiou V, Burroughs AK. HCV in liver transplantation. Semin Immunopathol. 2013;35:101-110. [PMID: 22829333 DOI: 10.1007/s00281-012-0329-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
129 Mohamed WA, Schaalan MF, El-Abhar HS. Camel Milk: Potential Utility as an Adjunctive Therapy to Peg-IFN/RBV in HCV-4 Infected Patients in Egypt. Nutr Cancer 2015;67:1305-13. [PMID: 26492130 DOI: 10.1080/01635581.2015.1087041] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
130 Arai T, Atsukawa M, Tsubota A, Kondo C, Shimada N, Abe H, Itokawa N, Nakagawa A, Okubo T, Aizawa Y, Iwakiri K. Vitamin D-related gene polymorphisms do not influence the outcome and serum vitamin D level in pegylated interferon/ribavirin therapy combined with protease inhibitor for patients with genotype 1b chronic hepatitis C: Vitamin D-Related Gene Polymorphisms for Hepatitis C. J Med Virol 2015;87:1904-12. [DOI: 10.1002/jmv.24244] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
131 Sakpal M, Satsangi S, Mehta M, Duseja A, Bhadada S, Das A, Dhiman RK, Chawla YK. Vitamin D supplementation in patients with nonalcoholic fatty liver disease: A randomized controlled trial. JGH Open. 2017;1:62-67. [PMID: 30483536 DOI: 10.1002/jgh3.12010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
132 Lange CM, Miki D, Ochi H, Nischalke HD, Bojunga J, Bibert S, Morikawa K, Gouttenoire J, Cerny A, Dufour JF. Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development. PLoS One. 2013;8:e64053. [PMID: 23734184 DOI: 10.1371/journal.pone.0064053] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 5.2] [Reference Citation Analysis]
133 Youssef DA, Miller CW, El-Abbassi AM, Cutchins DC, Cutchins C, Grant WB, Peiris AN. Antimicrobial implications of vitamin D. Dermatoendocrinol 2011;3:220-9. [PMID: 22259647 DOI: 10.4161/derm.3.4.15027] [Cited by in Crossref: 79] [Cited by in F6Publishing: 73] [Article Influence: 7.2] [Reference Citation Analysis]
134 Uçmak F, Yılmaz A, Ekin N, Ekinci A, Solmaz İ, Şenateş E. Vitamin D deficiency in patients with chronic hepatitis D viral infection. Clin Exp Hepatol 2021;7:141-8. [PMID: 34295980 DOI: 10.5114/ceh.2021.106505] [Reference Citation Analysis]
135 Trauner M, Halilbasic E. Nuclear receptors as new perspective for the management of liver diseases. Gastroenterology. 2011;140:1120-1125.e1-12. [PMID: 21334334 DOI: 10.1053/j.gastro.2011.02.044] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 6.6] [Reference Citation Analysis]
136 Chokuda E, Reynolds C, Das S. Association of Low Vitamin D with Complications of HIV and AIDS: A literature Review. Infect Disord Drug Targets 2020;20:122-42. [PMID: 30574856 DOI: 10.2174/1871526519666181221122731] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
137 Czaja AJ. Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions. Gut Liver. 2016;10:177-203. [PMID: 26934884 DOI: 10.5009/gnl15352] [Cited by in Crossref: 82] [Cited by in F6Publishing: 69] [Article Influence: 13.7] [Reference Citation Analysis]
138 Ghosn J, Viard JP. [Vitamin D and infectious diseases]. Presse Med 2013;42:1371-6. [PMID: 24051165 DOI: 10.1016/j.lpm.2013.07.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
139 Efe C, Purnak T, Ozaslan E. Vitamin D levels in patients with chronic hepatitis B. Hepatology 2014;60:768. [PMID: 24310781 DOI: 10.1002/hep.26962] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
140 Vachon MC, Dieterich DT. The HIV/HCV-Coinfected Patient and New Treatment Options. Clinics in Liver Disease 2011;15:585-96. [DOI: 10.1016/j.cld.2011.05.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
141 Yuan F, Wang N, Chen Y, Huang X, Yang Z, Xu Y, You K, Zhang J, Wang G, Zhuang Y, Pan T, Xiong Y, Yu X, Yang F, Li Y. Calcitriol promotes the maturation of hepatocyte-like cells derived from human pluripotent stem cells. J Steroid Biochem Mol Biol 2021;211:105881. [PMID: 33766737 DOI: 10.1016/j.jsbmb.2021.105881] [Reference Citation Analysis]
142 Atsukawa M, Tsubota A, Shimada N, Yoshizawa K, Abe H, Asano T, Ohkubo Y, Araki M, Ikegami T, Kondo C. Influencing factors on serum 25-hydroxyvitamin D3 levels in Japanese chronic hepatitis C patients. BMC Infect Dis. 2015;15:344. [PMID: 26286329 DOI: 10.1186/s12879-015-1020-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
143 Petta S, Grimaudo S, Marco VD, Scazzone C, Macaluso FS, Cammà C, Cabibi D, Pipitone R, Craxì A. Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients. J Viral Hepat. 2013;20:486-493. [PMID: 23730842 DOI: 10.1111/jvh.12072] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
144 Hu YC, Wang WW, Jiang WY, Li CQ, Guo JC, Xun YH. Low vitamin D levels are associated with high viral loads in patients with chronic hepatitis B: a systematic review and meta-analysis. BMC Gastroenterol. 2019;19:84. [PMID: 31185932 DOI: 10.1186/s12876-019-1004-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
145 Oliveira KS, Buss C, Tovo CV. Is there an association between vitamin D and liver fibrosis in patients with chronic hepatitis C? Arq Gastroenterol 2017;54:57-9. [PMID: 28079241 DOI: 10.1590/S0004-2803.2017v54n1-11] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
146 Geier A. Shedding new light on vitamin D and fatty liver disease. J Hepatol 2011;55:273-5. [PMID: 21236303 DOI: 10.1016/j.jhep.2010.12.026] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
147 Bitetto D, Fattovich G, Fabris C, Ceriani E, Falleti E, Fornasiere E, Pasino M, Ieluzzi D, Cussigh A, Cmet S, Pirisi M, Toniutto P. Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C. Hepatology 2011;53:1118-26. [PMID: 21480318 DOI: 10.1002/hep.24201] [Cited by in Crossref: 101] [Cited by in F6Publishing: 112] [Article Influence: 9.2] [Reference Citation Analysis]
148 Saab S, Jackson C, Nieto J, Francois F. Hepatitis C in African Americans. Am J Gastroenterol 2014;109:1576-84; quiz 1575, 1585. [PMID: 25178700 DOI: 10.1038/ajg.2014.243] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
149 Zhu M, Xu LM. Relationship between vitamin D and chronic liver diseases. Shijie Huaren Xiaohua Zazhi 2013; 21(18): 1714-1719 [DOI: 10.11569/wcjd.v21.i18.1714] [Reference Citation Analysis]
150 Terrier B, Lapidus N, Pol S, Serfaty L, Ratziu V, Asselah T, Thibault V, Souberbielle JC, Carrat F, Cacoub P. Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study. World J Gastroenterol 2015; 21(18): 5647-5653 [PMID: 25987791 DOI: 10.3748/wjg.v21.i18.5647] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
151 Hoan NX, Khuyen N, Giang DP, Binh MT, Toan NL, Anh DT, Trung NT, Bang MH, Meyer CG, Velavan TP, Song LH. Vitamin D receptor ApaI polymorphism associated with progression of liver disease in Vietnamese patients chronically infected with hepatitis B virus. BMC Med Genet 2019;20:201. [PMID: 31864292 DOI: 10.1186/s12881-019-0903-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
152 Ren Y, Liu M, Zhao J, Ren F, Chen Y, Li JF, Zhang JY, Qu F, Zhang JL, Duan ZP, Zheng SJ. Serum vitamin D3 does not correlate with liver fibrosis in chronic hepatitis C. World J Gastroenterol 2015; 21(39): 11152-11159 [PMID: 26494969 DOI: 10.3748/wjg.v21.i39.11152] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
153 Agmon-Levin N, Kopilov R, Selmi C, Nussinovitch U, Sánchez-Castañón M, López-Hoyos M, Amital H, Kivity S, Gershwin EM, Shoenfeld Y. Vitamin D in primary biliary cirrhosis, a plausible marker of advanced disease. Immunol Res 2015;61:141-6. [PMID: 25424577 DOI: 10.1007/s12026-014-8594-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
154 Khedr MA, Sira AM, Saber MA, Raia GY. Serum Adiponectin, Vitamin D, and Alpha-Fetoprotein in Children with Chronic Hepatitis C: Can They Predict Treatment Response? Int J Hepatol 2015;2015:617623. [PMID: 26640716 DOI: 10.1155/2015/617623] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
155 Bjelakovic G, Nikolova D, Bjelakovic M, Gluud C; Cochrane Hepato-Biliary Group. Vitamin D supplementation for chronic liver diseases in adults. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd011564] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
156 Wang CC, Tzeng IS, Su WC, Li CH, Lin HH, Yang CC, Kao JH. The association of vitamin D with hepatitis B virus replication: Bystander rather than offender. J Formos Med Assoc 2020;119:1634-41. [PMID: 31932201 DOI: 10.1016/j.jfma.2019.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
157 Gomes TL, Fernandes RC, Vieira LL, Schincaglia RM, Mota JF, Nóbrega MS, Pichard C, Pimentel GD. Low vitamin D at ICU admission is associated with cancer, infections, acute respiratory insufficiency, and liver failure. Nutrition 2019;60:235-40. [PMID: 30682545 DOI: 10.1016/j.nut.2018.10.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
158 El Awady MK, Bader El Din NG, Tabll A, El Hosary Y, Abdel Aziz AO, El Khayat H, Salama M, Abdelhafez TH. IL28B polymorphism and cytomegalovirus predict response to treatment in Egyptian HCV type 4 patients. World J Gastroenterol 2013;19:290-8. [PMID: 23345953 DOI: 10.3748/wjg.v19.i2.290] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
159 Efe C, Kav T, Aydin C, Cengiz M, Imga NN, Purnak T, Smyk DS, Torgutalp M, Turhan T, Ozenirler S, Ozaslan E, Bogdanos DP. Low serum vitamin D levels are associated with severe histological features and poor response to therapy in patients with autoimmune hepatitis. Dig Dis Sci. 2014;59:3035-3042. [PMID: 25002309 DOI: 10.1007/s10620-014-3267-3] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 7.6] [Reference Citation Analysis]
160 Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, Leblanc M, Coulter S, He M, Scott C, Lau SL, Atkins AR, Barish GD, Gunton JE, Liddle C, Downes M, Evans RM. A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell. 2013;153:601-613. [PMID: 23622244 DOI: 10.1016/j.cell.2013.03.028] [Cited by in Crossref: 386] [Cited by in F6Publishing: 389] [Article Influence: 42.9] [Reference Citation Analysis]
161 Esrefoglu M. Oxidative Stress and Benefits of Antioxidant Agents in Acute and Chronic Hepatitis. Hepat Mon 2012;12:160-7. [DOI: 10.5812/hepatmon.5090] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
162 Azmi H, Hassou N, Ennaji MM. Vitamin D Immunomodulatory Role in Chronic and Acute Viral Diseases. Emerging and Reemerging Viral Pathogens. Elsevier; 2020. pp. 489-506. [DOI: 10.1016/b978-0-12-819400-3.00022-3] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
163 Jin CN, Chen JD, Sheng JF. Vitamin D deficiency in hepatitis C virus infection: what is old? what is new? Eur J Gastroenterol Hepatol 2018;30:741-6. [PMID: 29664746 DOI: 10.1097/MEG.0000000000001134] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
164 Matsumura T, Kato T, Sugiyama N, Tasaka-Fujita M, Murayama A, Masaki T, Wakita T, Imawari M. 25-Hydroxyvitamin D3 suppresses hepatitis C virus production. Hepatology 2012;56:1231-9. [PMID: 22487892 DOI: 10.1002/hep.25763] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 5.9] [Reference Citation Analysis]
165 Yu R, Sun J, Zheng Z, Chen J, Fan R, Liang X, Zhu Y, Liu Y, Shen S, Hou J. Association between vitamin D level and viral load or fibrosis stage in chronic hepatitis B patients from Southern China. J Gastroenterol Hepatol. 2015;30:566-574. [PMID: 25238258 DOI: 10.1111/jgh.12783] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
166 Ji HF. Vitamin D levels may explain the racial differences in response rates to antiviral therapy for chronic hepatitis C. Hepatology 2011;54:1489. [PMID: 21618570 DOI: 10.1002/hep.24447] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
167 Khan MA, Dar HA, Baba MA, Shah AH, Singh B, Shiekh NA. Impact of Vitamin D Status in Chronic Liver Disease. J Clin Exp Hepatol 2019;9:574-80. [PMID: 31695247 DOI: 10.1016/j.jceh.2019.03.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
168 Duan X, Guan Y, Li Y, Chen S, Li S, Chen L. Vitamin D Potentiates the Inhibitory Effect of MicroRNA-130a in Hepatitis C Virus Replication Independent of Type I Interferon Signaling Pathway. Mediators Inflamm 2015;2015:508989. [PMID: 26060358 DOI: 10.1155/2015/508989] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
169 Runyon BA. A Primer on Detecting Cirrhosis and Caring for These Patients without Causing Harm. Int J Hepatol. 2011;2011:801983. [PMID: 22121492 DOI: 10.4061/2011/801983] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
170 Gabr SA, Alghadir AH, Allam AA, Ajarem J, Al-Basher G, Abdel-Maksoud MA, Ghfar AA, Aboud A. Correlation between vitamin D levels and apoptosis in geriatric patients infected with hepatitis C virus genotype 4. Clin Interv Aging 2016;11:523-33. [PMID: 27217734 DOI: 10.2147/CIA.S104599] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
171 Ripoli M, Pazienza V. Impact of HCV genetic differences on pathobiology of disease. Expert Rev Anti Infect Ther 2011;9:747-59. [PMID: 21905784 DOI: 10.1586/eri.11.94] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
172 Macaluso FS, Maida M, Minissale MG, Li Vigni T, Attardo S, Orlando E, Petta S. Metabolic factors and chronic hepatitis C: a complex interplay. Biomed Res Int. 2013;2013:564645. [PMID: 23956991 DOI: 10.1155/2013/564645] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
173 Oiso N, Sato M, Kawada A. Vitiligo after combination therapy of pegylated interferon-α-2a, ribavirin and vitamin D in a patient with chronic hepatitis C. J Dermatol 2013;40:772-3. [PMID: 23855823 DOI: 10.1111/1346-8138.12234] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
174 Chen EQ, Bai L, Zhou TY, Fe M, Zhang DM, Tang H. Sustained suppression of viral replication in improving vitamin D serum concentrations in patients with chronic hepatitis B. Sci Rep. 2015;5:15441. [PMID: 26486883 DOI: 10.1038/srep15441] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
175 Jeong JY, Jun DW, Park SJ, Sohn JH, Kim SG, Lee SW, Jeong SW, Kim MY, Kim W, Shim JJ, Kim HS, Suk KT, Ahn SB. Effects of vitamin D supplements in patients with chronic hepatitis C: a randomized, multi-center, open label study. Korean J Intern Med 2020;35:1074-83. [PMID: 31710801 DOI: 10.3904/kjim.2018.273] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
176 Barchetta I, Carotti S, Labbadia G, Gentilucci UV, Muda AO, Angelico F, Silecchia G, Leonetti F, Fraioli A, Picardi A, Morini S, Cavallo MG. Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus. Hepatology 2012;56:2180-7. [PMID: 22753133 DOI: 10.1002/hep.25930] [Cited by in Crossref: 152] [Cited by in F6Publishing: 137] [Article Influence: 15.2] [Reference Citation Analysis]
177 Sun S, Xu M, Zhuang P, Chen G, Dong K, Dong R, Zheng S. Effect and mechanism of vitamin D activation disorder on liver fibrosis in biliary atresia. Sci Rep 2021;11:19883. [PMID: 34615940 DOI: 10.1038/s41598-021-99158-3] [Reference Citation Analysis]
178 Siddiqui M, Manansala JS, Abdulrahman HA, Nasrallah GK, Smatti MK, Younes N, Althani AA, Yassine HM. Immune Modulatory Effects of Vitamin D on Viral Infections. Nutrients 2020;12:E2879. [PMID: 32967126 DOI: 10.3390/nu12092879] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
179 Thanapirom K, Suksawatamnuay S, Sukeepaisarnjaroen W, Tangkijvanich P, Treeprasertsuk S, Thaimai P, Wasitthankasem R, Poovorawan Y, Komolmit P. Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients. BMC Gastroenterol 2017;17:54. [PMID: 28415985 DOI: 10.1186/s12876-017-0613-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
180 Wu MP, Zhang JW, Huang P, Han YP, Zhang Y, Peng ZH, Wang J, Zhu P, Su J, Yu RB, Li J, Yue M. Genetic variations in vitamin D receptor were associated with the outcomes of hepatitis C virus infection among Chinese population. J Hum Genet 2016;61:129-35. [PMID: 26446365 DOI: 10.1038/jhg.2015.117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
181 Haghgoo SM, Sharafi H, Alavian SM. Serum cytokines, adipokines and ferritin for non-invasive assessment of liver fibrosis in chronic liver disease: a systematic review. Clin Chem Lab Med 2019;57:577-610. [PMID: 30231008 DOI: 10.1515/cclm-2018-0357] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
182 Lange CM, Bibert S, Kutalik Z, Burgisser P, Cerny A, Dufour JF, Geier A, Gerlach TJ, Heim MH, Malinverni R, Negro F, Regenass S, Badenhoop K, Bojunga J, Sarrazin C, Zeuzem S, Müller T, Berg T, Bochud PY, Moradpour D; Swiss Hepatitis C Cohort Study Group. A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C. PLoS One 2012;7:e40159. [PMID: 22808108 DOI: 10.1371/journal.pone.0040159] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
183 Zhao J, Zheng SJ. Role of vitamin D in liver diseases. Shijie Huaren Xiaohua Zazhi 2014; 22(9): 1214-1218 [DOI: 10.11569/wcjd.v22.i9.1214] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
184 El-Maouche D, Mehta SH, Sutcliffe CG, Higgins Y, Torbenson MS, Moore RD, Thomas DL, Sulkowski MS, Brown TT. Vitamin D deficiency and its relation to bone mineral density and liver fibrosis in HIV-HCV coinfection. Antivir Ther. 2013;18:237-242. [PMID: 22910231 DOI: 10.3851/imp2264] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
185 Hu CQ, Xu M, Yang BB, Liu XJ, Bo QL, Zhang C, Xu DX. Vitamin D Deficiency Attenuates Acute Alcohol-Induced Hepatic Lipid Accumulation in Mice. Lipids 2019;54:651-63. [PMID: 31463983 DOI: 10.1002/lipd.12188] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
186 Küçükazman M, Ata N, Dal K, Yeniova AÖ, Kefeli A, Basyigit S, Aktas B, Akin KO, Ağladıoğlu K, Üre ÖS, Topal F, Nazligül Y, Beyan E, Ertugrul DT. The association of vitamin D deficiency with non-alcoholic fatty liver disease. Clinics (Sao Paulo) 2014;69:542-6. [PMID: 25141113 DOI: 10.6061/clinics/2014(08)07] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
187 Kim TY. Role of vitamin D in chronic hepatitis C. Korean J Hepatol 2011;17:170. [DOI: 10.3350/kjhep.2011.17.2.170] [Reference Citation Analysis]
188 Lange CM, Gouttenoire J, Duong FH, Morikawa K, Heim MH, Moradpour D. Vitamin D receptor and Jak-STAT signaling crosstalk results in calcitriol-mediated increase of hepatocellular response to IFN-α. J Immunol 2014;192:6037-44. [PMID: 24821973 DOI: 10.4049/jimmunol.1302296] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 5.5] [Reference Citation Analysis]
189 Marino R, Misra M. Extra-Skeletal Effects of Vitamin D. Nutrients 2019;11:E1460. [PMID: 31252594 DOI: 10.3390/nu11071460] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
190 Terrier B, Carrat F, Geri G, Pol S, Piroth L, Halfon P, Poynard T, Souberbielle J, Cacoub P. Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis. Journal of Hepatology 2011;55:756-61. [DOI: 10.1016/j.jhep.2011.01.041] [Cited by in Crossref: 69] [Cited by in F6Publishing: 74] [Article Influence: 6.3] [Reference Citation Analysis]
191 Nobili V, Giorgio V, Liccardo D, Bedogni G, Morino G, Alisi A, Cianfarani S. Vitamin D levels and liver histological alterations in children with nonalcoholic fatty liver disease. Eur J Endocrinol. 2014;170:547-553. [PMID: 24412930 DOI: 10.1530/eje-13-0609] [Cited by in Crossref: 68] [Cited by in F6Publishing: 42] [Article Influence: 8.5] [Reference Citation Analysis]
192 Lange CM, Kutalik Z, Morikawa K, Bibert S, Cerny A, Dollenmaier G, Dufour JF, Gerlach TJ, Heim MH, Malinverni R, Müllhaupt B, Negro F, Moradpour D, Bochud PY; Swiss Hepatitis C Cohort Study Group. Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy. Hepatology 2012;55:1038-47. [PMID: 22095909 DOI: 10.1002/hep.24787] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
193 Reese PP, Bloom RD, Feldman HI, Huverserian A, Thomasson A, Shults J, Hamano T, Goral S, Shaked A, Olthoff K. Changes in vitamin D binding protein and vitamin D concentrations associated with liver transplantation. Liver Int. 2012;32:287-296. [PMID: 22098635 DOI: 10.1111/j.1478-3231.2011.02638.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
194 Wu M, Yue M, Huang P, Zhang Y, Xie C, Yu R, Li J, Wang J. Vitamin D level and vitamin D receptor genetic variations contribute to HCV infection susceptibility and chronicity in a Chinese population. Infect Genet Evol 2016;41:146-52. [PMID: 27063396 DOI: 10.1016/j.meegid.2016.03.032] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
195 Jun CH, Ki HS, Lee HK, Park KJ, Park SY, Cho SB, Park CH, Joo YE, Kim HS, Choi SK, Rew JS. Clinical significance and risk factors of postembolization fever in patients with hepatocellular carcinoma. World J Gastroenterol 2013; 19(2): 284-289 [PMID: 23345952 DOI: 10.3748/wjg.v19.i2.284] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
196 Gutierrez JA, Parikh N, Branch AD. Classical and emerging roles of vitamin D in hepatitis C virus infection. Semin Liver Dis. 2011;31:387-398. [PMID: 22189978 DOI: 10.1055/s-0031-1297927] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 4.8] [Reference Citation Analysis]
197 Zhuang P, Sun S, Dong R, Chen G, Huang Y, Zheng S. Associations between Vitamin D and Liver Function and Liver Fibrosis in Patients with Biliary Atresia. Gastroenterol Res Pract 2019;2019:4621372. [PMID: 31781188 DOI: 10.1155/2019/4621372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
198 Bitetto D, Fabris C, Fornasiere E, Pipan C, Fumolo E, Cussigh A, Bignulin S, Cmet S, Fontanini E, Falleti E. Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C. Transpl Int. 2011;24:43-50. [PMID: 20649944 DOI: 10.1111/j.1432-2277.2010.01141.x] [Cited by in Crossref: 102] [Cited by in F6Publishing: 105] [Article Influence: 9.3] [Reference Citation Analysis]
199 Hoan NX, Khuyen N, Binh MT, Giang DP, Van Tong H, Hoan PQ, Trung NT, Anh DT, Toan NL, Meyer CG. Association of vitamin D deficiency with hepatitis B virus - related liver diseases. BMC Infect Dis. 2016;16:507. [PMID: 27659316 DOI: 10.1186/s12879-016-1836-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
200 Anty R, Tonohouan M, Ferrari-Panaia P, Piche T, Pariente A, Anstee QM, Gual P, Tran A. Low Levels of 25-Hydroxy Vitamin D are Independently Associated with the Risk of Bacterial Infection in Cirrhotic Patients. Clin Transl Gastroenterol. 2014;5:e56. [PMID: 24871371 DOI: 10.1038/ctg.2014.6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
201 Zúñiga S, Firrincieli D, Housset C, Chignard N. Vitamin D and the vitamin D receptor in liver pathophysiology. Clin Res Hepatol Gastroenterol 2011;35:295-302. [PMID: 21440524 DOI: 10.1016/j.clinre.2011.02.003] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
202 Mandorfer M, Reiberger T, Payer BA, Ferlitsch A, Breitenecker F, Aichelburg MC, Obermayer-Pietsch B, Rieger A, Trauner M, Peck-Radosavljevic M; Vienna HIV & Liver Study Group. Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients. AIDS 2013;27:227-32. [PMID: 23238552 DOI: 10.1097/QAD.0b013e32835aa161] [Cited by in Crossref: 37] [Cited by in F6Publishing: 21] [Article Influence: 4.1] [Reference Citation Analysis]
203 Imawari M. Does vitamin D supplementation improve sustained virological response in cirrhotic patients with hepatitis C virus genotype 1b and high viral load? Hepatol Res 2014;44:1265-7. [PMID: 25409555 DOI: 10.1111/hepr.12328] [Reference Citation Analysis]
204 Wong GL, Chan HL, Chan HY, Tse CH, Chim AM, Lo AO, Wong VW. Adverse effects of vitamin D deficiency on outcomes of patients with chronic hepatitis B. Clin Gastroenterol Hepatol. 2015;13:783-790.e1. [PMID: 25445773 DOI: 10.1016/j.cgh.2014.09.050] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 4.8] [Reference Citation Analysis]
205 Morisco F, Colao A, Guarino M, Lembo V, Granata R, Donnarumma L, Auriemma F, Mariniello A, Mazzone G, Di Somma C, Rubino M, Cariati F, Pivonello C, Loperto I, Caporaso N. Vitamin D levels and chronic hepatitis C. e-SPEN Journal 2013;8:e169-74. [DOI: 10.1016/j.clnme.2013.04.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
206 Gonzalez-Sanchez E, El Mourabit H, Jager M, Clavel M, Moog S, Vaquero J, Ledent T, Cadoret A, Gautheron J, Fouassier L, Wendum D, Chignard N, Housset C. Cholangiopathy aggravation is caused by VDR ablation and alleviated by VDR-independent vitamin D signaling in ABCB4 knockout mice. Biochim Biophys Acta Mol Basis Dis 2021;1867:166067. [PMID: 33418034 DOI: 10.1016/j.bbadis.2020.166067] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
207 Gerova DI, Galunska BT, Ivanova II, Kotzev IA, Tchervenkov TG, Balev SP, Svinarov DA. Prevalence of vitamin D deficiency and insufficiency in Bulgarian patients with chronic hepatitis C viral infection. Scand J Clin Lab Invest. 2014;74:665-672. [PMID: 25005344 DOI: 10.3109/00365513.2014.930710] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
208 Reins RY, McDermott AM. Vitamin D: Implications for ocular disease and therapeutic potential. Exp Eye Res 2015;134:101-10. [PMID: 25724179 DOI: 10.1016/j.exer.2015.02.019] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 5.6] [Reference Citation Analysis]
209 Stokes CS, Volmer DA, Grünhage F, Lammert F. Vitamin D in chronic liver disease. Liver Int 2013;33:338-52. [DOI: 10.1111/liv.12106] [Cited by in Crossref: 92] [Cited by in F6Publishing: 83] [Article Influence: 10.2] [Reference Citation Analysis]
210 Higa GM, Hicks J, Isabella C. Adjudication of the alleged role of vitamin d in the antimicrobial pathway. Scientifica (Cairo) 2012;2012:129516. [PMID: 24278668 DOI: 10.6064/2012/129516] [Reference Citation Analysis]
211 Fiorino S, Conti F, Gramenzi A, Loggi E, Cursaro C, Di Donato R, Micco L, Gitto S, Cuppini A, Bernardi M, Andreone P. Vitamins in the treatment of chronic viral hepatitis. Br J Nutr 2011;105:982-9. [PMID: 21255469 DOI: 10.1017/S0007114510004629] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
212 Mongy NNE, Hilal RF. How far is vitamin D implicated in cutaneous infections. Clin Dermatol 2021:S0738-081X(21)00215-7. [PMID: 34893391 DOI: 10.1016/j.clindermatol.2021.10.003] [Reference Citation Analysis]
213 Petta S, Di Marco V, Di Stefano R, Cabibi D, Cammà C, Marchesini G, Craxì A. TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1. Journal of Viral Hepatitis 2011;18. [DOI: 10.1111/j.1365-2893.2011.01439.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
214 Belle A, Gizard E, Conroy G, Lopez A, Bouvier-Alias M, Rouanet S, Peyrin-Biroulet L, Pawlotsky JM, Bronowicki JP. 25-OH vitamin D level has no impact on the efficacy of antiviral therapy in naïve genotype 1 HCV-infected patients. United European Gastroenterol J 2017;5:69-75. [PMID: 28405324 DOI: 10.1177/2050640616640157] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
215 Branch AD, Kang M, Hollabaugh K, Wyatt CM, Chung RT, Glesby MJ. In HIV/hepatitis C virus co-infected patients, higher 25-hydroxyvitamin D concentrations were not related to hepatitis C virus treatment responses but were associated with ritonavir use. Am J Clin Nutr 2013;98:423-9. [PMID: 23739141 DOI: 10.3945/ajcn.112.048785] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
216 Bulathsinghala P, Syrigos KN, Saif MW. Role of vitamin d in the prevention of pancreatic cancer. J Nutr Metab 2010;2010:721365. [PMID: 21274445 DOI: 10.1155/2010/721365] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
217 Guzmán-Fulgencio M, García-Álvarez M, Berenguer J, Jiménez-Sousa MÁ, Cosín J, Pineda-Tenor D, Carrero A, Aldámiz T, Alvarez E, López JC, Resino S. Vitamin D deficiency is associated with severity of liver disease in HIV/HCV coinfected patients. J Infect. 2014;68:176-184. [PMID: 24184809 DOI: 10.1016/j.jinf.2013.10.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
218 Petta S, Amato M, Cabibi D, Cammà C, Di Marco V, Giordano C, Galluzzo A, Craxì A. Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1. Hepatology 2010;52:1543-52. [PMID: 20799355 DOI: 10.1002/hep.23859] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 6.0] [Reference Citation Analysis]
219 Gueli N, Verrusio W, Linguanti A, Di Maio F, Martinez A, Marigliano B, Cacciafesta M. Vitamin D: drug of the future. A new therapeutic approach. Arch Gerontol Geriatr 2012;54:222-7. [PMID: 21458871 DOI: 10.1016/j.archger.2011.03.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
220 Czaja AJ, Montano-Loza AJ. Evolving Role of Vitamin D in Immune-Mediated Disease and Its Implications in Autoimmune Hepatitis. Dig Dis Sci. 2019;64:324-344. [PMID: 30370494 DOI: 10.1007/s10620-018-5351-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
221 Han YP, Kong M, Zheng S, Ren Y, Zhu L, Shi H, Duan Z. Vitamin D in liver diseases: from mechanisms to clinical trials. J Gastroenterol Hepatol. 2013;28 Suppl 1:49-55. [PMID: 23855296 DOI: 10.1111/jgh.12016] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
222 Triantos C, Kalafateli M, Aggeletopoulou I, Diamantopoulou G, Spantidea PI, Michalaki M, Vourli G, Konstantakis C, Assimakopoulos SF, Manolakopoulos S, Gogos C, Kyriazopoulou V, Mouzaki A, Thomopoulos K. Vitamin D-related immunomodulation in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 2020;32:867-76. [PMID: 31789949 DOI: 10.1097/MEG.0000000000001597] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
223 European Association for the Study of the Liver. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol. 2019;70:172-193. [PMID: 30144956 DOI: 10.1016/j.jhep.2018.06.024] [Cited by in Crossref: 207] [Cited by in F6Publishing: 160] [Article Influence: 51.8] [Reference Citation Analysis]
224 He X, Xu C, Lu ZH, Fang XZ, Tan J, Song Y. Low serum 25-hydroxyvitamin D levels are associated with liver injury markers in the US adult population. Public Health Nutr 2020;23:2915-22. [PMID: 32576302 DOI: 10.1017/S1368980020000348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
225 Udomsinprasert W, Jittikoon J, Sukkho S, Pojarassangkul N, Sangroongruangsri S, Chaikledkaew U. Decreased circulating vitamin D reflects adverse outcomes of hepatitis C virus infection: A systematic review and meta-analysis. J Infect 2020;81:585-99. [PMID: 32553842 DOI: 10.1016/j.jinf.2020.06.025] [Reference Citation Analysis]
226 Villar LM, Del Campo JA, Ranchal I, Lampe E, Romero-Gomez M. Association between vitamin D and hepatitis C virus infection: A meta-analysis. World J Gastroenterol 2013; 19(35): 5917-5924 [PMID: 24124339 DOI: 10.3748/wjg.v19.i35.5917] [Cited by in CrossRef: 64] [Cited by in F6Publishing: 54] [Article Influence: 7.1] [Reference Citation Analysis]
227 Esmat G, El Raziky M, Elsharkawy A, Sabry D, Hassany M, Ahmed A, Assem N, El Kassas M, Doss W. Impact of vitamin D supplementation on sustained virological response in chronic hepatitis C genotype 4 patients treated by pegylated interferon/ribavirin. J Interferon Cytokine Res. 2015;35:49-54. [PMID: 25061714 DOI: 10.1089/jir.2014.0060] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
228 Queiroga Mde L, Paraná R, Medeiros Filho JE, Figueiredo GC, Araújo AP, Leite HW, Aquino Ide S, Melo Neto LH. GAMMA GLUTAMYLTRANSFERASE IMPACT IN THERAPEUTIC RESPONSE OF CHRONIC HEPATITIS C: a systematic review of the literature. Arq Gastroenterol 2015;52:239-46. [PMID: 26486294 DOI: 10.1590/S0004-28032015000300016] [Reference Citation Analysis]
229 Guo J, Ma Z, Ma Q, Wu Z, Fan P, Zhou X, Chen L, Zhou S, Goltzman D, Miao D, Wu E. 1, 25(OH)₂D₃ inhibits hepatocellular carcinoma development through reducing secretion of inflammatory cytokines from immunocytes. Curr Med Chem 2013;20:4131-41. [PMID: 23992309 DOI: 10.2174/09298673113209990248] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
230 Firrincieli D, Braescu T, Housset C, Chignard N. Illuminating liver fibrosis with vitamin D. Clin Res Hepatol Gastroenterol. 2014;38:5-8. [PMID: 24238723 DOI: 10.1016/j.clinre.2013.10.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
231 Abdrabbo M, Birch CM, Brandt M, Cicigoi KA, Coffey SJ, Dolan CC, Dvorak H, Gehrke AC, Gerzema AEL, Hansen A, Henseler EJ, Huelsbeck AC, LaBerge B, Leavens CM, Le CN, Lindquist AC, Ludwig RK, Reynolds JH, Severson NJ, Sherman BA, Sillman HW, Smith MA, Smith MA, Snortheim MJ, Svaren LM, Vanderpas EC, Wackett MJ, Wozney AJ, Bhattacharyya S, Hati S. Vitamin D and COVID-19: A review on the role of vitamin D in preventing and reducing the severity of COVID-19 infection. Protein Sci 2021;30:2206-20. [PMID: 34558135 DOI: 10.1002/pro.4190] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
232 Fernández Rodriguez CM, Gutierrez Garcia ML. [Impact of antiviral therapy on the natural history of hepatitis C virus]. Gastroenterol Hepatol 2014;37:583-92. [PMID: 25066318 DOI: 10.1016/j.gastrohep.2014.05.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
233 Esrefoglu M. Oxidative stress and benefits of antioxidant agents in acute and chronic hepatitis. Hepat Mon. 2012;12:160-167. [PMID: 22550523 DOI: 10.5812/hepatmon.837] [Cited by in Crossref: 6] [Cited by in F6Publishing: 20] [Article Influence: 0.6] [Reference Citation Analysis]
234 Lương KVQ, Nguyễn LTH. Theoretical basis of a beneficial role for vitamin D in viral hepatitis. World J Gastroenterol 2012; 18(38): 5338-5350 [PMID: 23082050 DOI: 10.3748/wjg.v18.i38.5338] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
235 Pacifico L, Osborn JF, Bonci E, Pierimarchi P, Chiesa C. Association between Vitamin D Levels and Nonalcoholic Fatty Liver Disease: Potential Confounding Variables. Mini Rev Med Chem 2019;19:310-32. [PMID: 30360708 DOI: 10.2174/1389557518666181025153712] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
236 Czaja AJ. Transitioning from Idiopathic to Explainable Autoimmune Hepatitis. Dig Dis Sci. 2015;60:2881-2900. [PMID: 25999246 DOI: 10.1007/s10620-015-3708-7] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 5.6] [Reference Citation Analysis]
237 Potter JJ, Liu X, Koteish A, Mezey E. 1,25-dihydroxyvitamin D3 and its nuclear receptor repress human α1 (I) collagen expression and type I collagen formation. Liver Int. 2013;33:677-686. [PMID: 23413886 DOI: 10.1111/liv.12122] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
238 Sabry D, Al-Ghussein MA, Hamdy G, Abul-Fotouh A, Motawi T, El Kazaz AY, Eldemery A, Shaker M. Effect of vitamin D therapy on interleukin-6, visfatin, and hyaluronic acid levels in chronic hepatitis C Egyptian patients. Ther Clin Risk Manag 2015;11:279-88. [PMID: 25737638 DOI: 10.2147/TCRM.S66763] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
239 Wan LY, Zhang YQ, Li JM, Tang HQ, Chen MD, Ni YR, Huang H, Liu CB, Wu JF. Liganded Vitamin D Receptor Through Its Interacting Repressor Inhibits the Expression of Type I Collagen α1. DNA Cell Biol 2016;35:498-505. [PMID: 27351590 DOI: 10.1089/dna.2016.3367] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
240 Grammatikos G, Lange C, Susser S, Schwendy S, Dikopoulos N, Buggisch P, Encke J, Teuber G, Goeser T, Thimme R. Vitamin D levels vary during antiviral treatment but are unable to predict treatment outcome in HCV genotype 1 infected patients. PLoS One. 2014;9:e87974. [PMID: 24516573 DOI: 10.1371/journal.pone.0087974] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
241 Luo YQ, Wu XX, Ling ZX, Cheng YW, Yuan L, Xiang C. Association between serum vitamin D and severity of liver fibrosis in chronic hepatitis C patients: a systematic meta-analysis. J Zhejiang Univ Sci B. 2014;15:900-906. [PMID: 25294379 DOI: 10.1631/jzus.b1400073] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
242 Forde KA, Reddy KR. Hormones: A Potential Explanation for Differences in Response Rates to Therapy for Chronic Hepatitis C Infection. Gastroenterology 2011;140:776-9. [DOI: 10.1053/j.gastro.2011.01.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
243 Udomsinprasert W, Jittikoon J. Vitamin D and liver fibrosis: Molecular mechanisms and clinical studies. Biomed Pharmacother. 2019;109:1351-1360. [PMID: 30551386 DOI: 10.1016/j.biopha.2018.10.140] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
244 Salmi L, Barbaglia MN, Smirne C, Bianco S, Guaschino G, Crobu MGS, Minisini R, Pirisi M. Detrimental Impact of Interferon-Based Regimens for Chronic Hepatitis C on Vitamin D/Parathyroid Hormone Homeostasis. TORJ 2018;12:279-88. [DOI: 10.2174/1874312901812010279] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
245 Konstantakis C, Tselekouni P, Kalafateli M, Triantos C. Vitamin D deficiency in patients with liver cirrhosis. Ann Gastroenterol 2016;29:297-306. [PMID: 27366029 DOI: 10.20524/aog.2016.0037] [Cited by in Crossref: 22] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
246 Terrier B, Jehan F, Munteanu M, Geri G, Saadoun D, Sène D, Poynard T, Souberbielle JC, Cacoub P. Low 25-hydroxyvitamin D serum levels correlate with the presence of extra-hepatic manifestations in chronic hepatitis C virus infection. Rheumatology (Oxford). 2012;51:2083-2090. [PMID: 22908327 DOI: 10.1093/rheumatology/kes209] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
247 Branch AD, Barin B, Rahman A, Stock P, Schiano TD. Vitamin D status of human immunodeficiency virus-positive patients with advanced liver disease enrolled in the solid organ transplantation in HIV: multi-site study. Liver Transpl 2014;20:156-64. [PMID: 24338934 DOI: 10.1002/lt.23784] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
248 Licata A, Novo G, Colomba D, Tuttolomondo A, Galia M, Camma' C. Cardiac involvement in patients with cirrhosis: a focus on clinical features and diagnosis. J Cardiovasc Med (Hagerstown). 2016;17:26-36. [PMID: 26065511 DOI: 10.2459/JCM.0000000000000288] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
249 Ayadi A, Nafari AH, Sakhaee F, Rajabi K, Ghaderi Y, Rahimi Jamnani F, Vaziri F, Siadat SD, Fateh A. Host genetic factors and clinical parameters influencing the occult hepatitis C virus infection in patients on chronic hemodialysis: Is it still a controversial infection? Hepatol Res. 2019;49:605-616. [PMID: 30821879 DOI: 10.1111/hepr.13325] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
250 Aman W, Mousa S, Shiha G, Mousa SA. Current status and future directions in the management of chronic hepatitis C. Virol J. 2012;9:57. [PMID: 22385500 DOI: 10.1186/1743-422x-9-57] [Cited by in Crossref: 31] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
251 Shaker O, Nassar Y, Ayoub S, Elrazki M, Zahra A. Impact of FokI (rs10735810) and BsmI (rs1544410) on Treatment of Chronic HCV Patients With Genotype 4. J Clin Lab Anal 2016;30:1021-7. [PMID: 27087054 DOI: 10.1002/jcla.21974] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
252 Melo-villar L, Lampe E, de Almeida AJ, Scalioni LDP, Lewis-ximenez LL, Miguel JC, Del Campo JA, Ranchal I, Villela-nogueira CA, Romero-gomez M. Hypovitaminosis D and its relation to demographic and laboratory data among hepatitis C patients. Annals of Hepatology 2015;14:457-63. [DOI: 10.1016/s1665-2681(19)31166-4] [Cited by in Crossref: 11] [Article Influence: 1.6] [Reference Citation Analysis]
253 Tillmann HL. Vitamins? The magic bullet against hepatitis C. Expert Review of Anti-infective Therapy 2014;10:1273-7. [DOI: 10.1586/eri.12.127] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
254 Name JJ, Vasconcelos AR, Souza ACR, Fávaro WJ. Vitamin D, zinc and glutamine: Synergistic action with OncoTherad immunomodulator in interferon signaling and COVID‑19 (Review). Int J Mol Med 2021;47:11. [PMID: 33448317 DOI: 10.3892/ijmm.2021.4844] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
255 Özerkan D, Özsoy N, Akbulut KG, Güney Ş, Öztürk G. The protective effect of vitamin D against carbon tetrachloride damage to the rat liver. Biotech Histochem 2017;92:513-23. [PMID: 28910170 DOI: 10.1080/10520295.2017.1361549] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
256 Coppola N, Pisaturo M, Sagnelli C, Onorato L, Sagnelli E. Role of genetic polymorphisms in hepatitis C virus chronic infection. World J Clin Cases 2015; 3(9): 807-822 [PMID: 26380828 DOI: 10.12998/wjcc.v3.i9.807] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
257 Silva MC, Silva TE, Aires de Alentar ML, Coelho MSPH, Wildner LM, Bazzo ML, González-chica DA, Dantas-corrêa EB, Narciso-schiavon JL, Schiavon LDL. Factors associated with 25-hydroxyvitamin D levels in patients with liver cirrhosis. Annals of Hepatology 2015;14:99-107. [DOI: 10.1016/s1665-2681(19)30806-3] [Cited by in Crossref: 4] [Article Influence: 0.6] [Reference Citation Analysis]
258 Zhang Z, Rong L, Li YP. Flaviviridae Viruses and Oxidative Stress: Implications for Viral Pathogenesis. Oxid Med Cell Longev 2019;2019:1409582. [PMID: 31531178 DOI: 10.1155/2019/1409582] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
259 Eltayeb AA, Abdou MAA, Abdel-aal AM, Othman MH. Vitamin D status and viral response to therapy in hepatitis C infected children. World J Gastroenterol 2015; 21(4): 1284-1291 [PMID: 25632203 DOI: 10.3748/wjg.v21.i4.1284] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
260 Khan S, Ali A, Khan S, Bakillah A, Damanhouri G, Khan A, Makki A, AlAnsari I, Banu N. Current therapies in alleviating liver disorders and cancers with a special focus on the potential of vitamin D. Nutr Metab (Lond) 2018;15:13. [PMID: 29449867 DOI: 10.1186/s12986-018-0251-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
261 Schaalan MF, Mohamed WA, Amin HH. Vitamin D deficiency: Correlation to interleukin-17, interleukin-23 and PIIINP in hepatitis C virus genotype 4. World J Gastroenterol 2012; 18(28): 3738-3744 [PMID: 22851868 DOI: 10.3748/wjg.v18.i28.3738] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
262 Marzio DLHD, Fenkel JM. Complementary and alternative medications in hepatitis C infection. World J Hepatol 2014; 6(1): 9-16 [PMID: 24653790 DOI: 10.4254/wjh.v6.i1.9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
263 Hernández-Alvarez N, Pascasio Acevedo JM, Quintero E, Fernández Vázquez I, García-Eliz M, de la Revilla Negro J, Crespo García J, Hernández-Guerra M. Effect of season and sunlight on viral kinetics during hepatitis C virus therapy. BMJ Open Gastroenterol 2017;4:e000115. [PMID: 28321328 DOI: 10.1136/bmjgast-2016-000115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
264 Hashemi SJ, Parsi A, Hajiani E, Masjedizadeh A, Shayesteh A. Relationship Between 25-HydroxyVitamin D Level and Liver Stiffness in Patients with Chronic Hepatitis B Using Transient Elastography. Hepat Mon 2020;20. [DOI: 10.5812/hepatmon.100891] [Reference Citation Analysis]
265 White DL, Tavakoli-Tabasi S, Kanwal F, Ramsey DJ, Hashmi A, Kuzniarek J, Patel P, Francis J, El-Serag HB. The association between serological and dietary vitamin D levels and hepatitis C-related liver disease risk differs in African American and white males. Aliment Pharmacol Ther. 2013;38:28-37. [PMID: 23710689 DOI: 10.1111/apt.12341] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
266 Abdel-Mohsen MA, El-Braky AA, Ghazal AAE, Shamseya MM. Autophagy, apoptosis, vitamin D, and vitamin D receptor in hepatocellular carcinoma associated with hepatitis C virus. Medicine (Baltimore) 2018;97:e0172. [PMID: 29561429 DOI: 10.1097/MD.0000000000010172] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
267 Fedirko V, Duarte-Salles T, Bamia C, Trichopoulou A, Aleksandrova K, Trichopoulos D, Trepo E, Tjønneland A, Olsen A, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Kvaskoff M, Kühn T, Lukanova A, Boeing H, Buijsse B, Klinaki E, Tsimakidi C, Naccarati A, Tagliabue G, Panico S, Tumino R, Palli D, Bueno-de-Mesquita HB, Siersema PD, Peters PH, Lund E, Brustad M, Olsen KS, Weiderpass E, Zamora-Ros R, Sánchez MJ, Ardanaz E, Amiano P, Navarro C, Quirós JR, Werner M, Sund M, Lindkvist B, Malm J, Travis RC, Khaw KT, Stepien M, Scalbert A, Romieu I, Lagiou P, Riboli E, Jenab M. Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control study. Hepatology 2014;60:1222-30. [PMID: 24644045 DOI: 10.1002/hep.27079] [Cited by in Crossref: 70] [Cited by in F6Publishing: 75] [Article Influence: 8.8] [Reference Citation Analysis]
268 Kondo Y. Hepatitis C infected patients need vitamin D3 supplementation in the era of direct acting antivirals treatment. World J Gastroenterol 2017; 23(8): 1325-1327 [PMID: 28293078 DOI: 10.3748/wjg.v23.i8.1325] [Cited by in CrossRef: 1] [Article Influence: 0.2] [Reference Citation Analysis]
269 Hoan NX, Tong HV, Song LH, Meyer CG, Velavan TP. Vitamin D deficiency and hepatitis viruses-associated liver diseases: A literature review. World J Gastroenterol 2018; 24(4): 445-460 [PMID: 29398866 DOI: 10.3748/wjg.v24.i4.445] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
270 Chen HW, Chiu YL, Hsieh TY, Chen PJ, Huang TY, Lin HH, Shih YL, Lin JC. Relationships Between Vitamin D Status and Cytokine: Results from Interferon-Based Therapy in Non-Cirrhotic, Treatment-Naïve Patients with Chronic Hepatitis C Infection. J Inflamm Res 2020;13:1207-18. [PMID: 33402842 DOI: 10.2147/JIR.S283768] [Reference Citation Analysis]
271 Kitson MT, Roberts SK. D-livering the message: the importance of vitamin D status in chronic liver disease. J Hepatol. 2012;57:897-909. [PMID: 22634121 DOI: 10.1016/j.jhep.2012.04.033] [Cited by in Crossref: 134] [Cited by in F6Publishing: 121] [Article Influence: 13.4] [Reference Citation Analysis]
272 Bjelakovic G, Nikolova D, Bjelakovic M, Gluud C. Vitamin D supplementation for chronic liver diseases in adults. Cochrane Database Syst Rev. 2017;11:CD011564. [PMID: 29099543 DOI: 10.1002/14651858.cd011564.pub2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
273 Petta S, Macaluso FS, Craxì A. Cardiovascular diseases and HCV infection: a simple association or more? Gut 2014;63:369-75. [PMID: 24295849 DOI: 10.1136/gutjnl-2013-306102] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 6.8] [Reference Citation Analysis]
274 Cholongitas E, Theocharidou E, Goulis J, Tsochatzis E, Akriviadis E, Burroughs K. Review article: the extra-skeletal effects of vitamin D in chronic hepatitis C infection. Aliment Pharmacol Ther. 2012;35:634-646. [PMID: 22316435 DOI: 10.1111/j.1365-2036.2012.05000.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
275 Gupta S, Read SA, Shackel NA, Hebbard L, George J, Ahlenstiel G. The Role of Micronutrients in the Infection and Subsequent Response to Hepatitis C Virus. Cells 2019;8:E603. [PMID: 31212984 DOI: 10.3390/cells8060603] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
276 Hii CS, Ferrante A. The Non-Genomic Actions of Vitamin D. Nutrients 2016;8:135. [PMID: 26950144 DOI: 10.3390/nu8030135] [Cited by in Crossref: 102] [Cited by in F6Publishing: 94] [Article Influence: 17.0] [Reference Citation Analysis]
277 Atsukawa M, Tsubota A, Shimada N, Kondo C, Itokawa N, Nakagawa A, Hashimoto S, Fukuda T, Matsushita Y, Kidokoro H, Narahara Y, Nakatsuka K, Iwakiri K, Kawamoto C, Sakamoto C. Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study. Hepat Mon 2013;13:e14872. [PMID: 24403915 DOI: 10.5812/hepatmon.14872] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
278 Yousif MM, Sadek AMEM, Farrag HA, Selim FO, Hamed EF, Salama RI. Associated vitamin D deficiency is a risk factor for the complication of HCV-related liver cirrhosis including hepatic encephalopathy and spontaneous bacterial peritonitis. Intern Emerg Med 2019;14:753-61. [PMID: 30706253 DOI: 10.1007/s11739-019-02042-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
279 García-Martín E, Agúndez JA, Maestro ML, Suárez A, Vidaurreta M, Martínez C, Fernández-Pérez C, Ortega L, Ladero JM. Influence of vitamin D-related gene polymorphisms (CYP27B and VDR) on the response to interferon/ribavirin therapy in chronic hepatitis C. PLoS One. 2013;8:e74764. [PMID: 24073221 DOI: 10.1371/journal.pone.0074764] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
280 Komolmit P, Kimtrakool S, Suksawatamnuay S, Thanapirom K, Chattrasophon K, Thaimai P, Chirathaworn C, Poovorawan Y. Vitamin D supplementation improves serum markers associated with hepatic fibrogenesis in chronic hepatitis C patients: A randomized, double-blind, placebo-controlled study. Sci Rep 2017;7:8905. [PMID: 28827788 DOI: 10.1038/s41598-017-09512-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
281 El Awady MK, Bader El Din NG, Tabll A, El Hosary Y, Abdel Aziz AO, El Khayat H, Salama M, Abdelhafez TH. IL28B polymorphism and cytomegalovirus predict response to treatment in Egyptian HCV type 4 patients. World J Gastroenterol 2013;19:290-8. [PMID: 23345953 DOI: 10.3748/wjg.v19.i2.290] [Reference Citation Analysis]
282 Yu R, Tan D, Ning Q, Niu J, Bai X, Chen S, Cheng J, Yu Y, Wang H, Xu M, Shi G, Wan M, Chen X, Tang H, Sheng J, Dou X, Shi J, Ren H, Wang M, Zhang H, Gao Z, Chen C, Ma H, Jia J, Hou J, Xie Q, Sun J. Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B: Vitamin D level predicts virologic response. Hepatol Res 2018;48:E213-21. [DOI: 10.1111/hepr.12972] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
283 Celik S, Golbasi H, Gulucu S, Guclu M, Caliskan CS, Celik S, Akpak YK, Golbasi C. Role of Vitamin B12 and Vitamin D levels in intrahepatic cholestasis of pregnancy and correlation with total bile acid. J Obstet Gynaecol 2022;:1-6. [PMID: 35482784 DOI: 10.1080/01443615.2022.2042797] [Reference Citation Analysis]
284 Lee T, Tillmann HL, Patel K. Individualized Therapy for Hepatitis C Infection: Focus on the Interleukin-28B Polymorphism in Directing Therapy. Mol Diagn Ther 2014;18:25-38. [DOI: 10.1007/s40291-013-0053-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
285 Koop AH, Mousa OY, Pham LE, Corral-Hurtado JE, Pungpapong S, Keaveny AP. An Argument for Vitamin D, A, and Zinc Monitoring in Cirrhosis. Ann Hepatol 2018;17:920-32. [PMID: 30600288 DOI: 10.5604/01.3001.0012.7192] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
286 Kim TH, Yun SG, Choi J, Goh HG, Lee HA, Yim SY, Choi SJ, Lee YS, Yoon EL, Jung YK, Seo YS, Kim JH, Yim HJ, Yeon JE, Byun KS, Um SH. Differential Impact of Serum 25-Hydroxyvitamin D3 Levels on the Prognosis of Patients with Liver Cirrhosis According to MELD and Child-Pugh Scores. J Korean Med Sci 2020;35:e129. [PMID: 32419396 DOI: 10.3346/jkms.2020.35.e129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
287 de Almeida JP, Liberatti LS, Barros FE, Kallaur AP, Lozovoy MA, Scavuzzi BM, Panis C, Reiche EM, Dichi I, Simão AN. Profile of oxidative stress markers is dependent on vitamin D levels in patients with chronic hepatitis C. Nutrition 2016;32:362-7. [PMID: 26847403 DOI: 10.1016/j.nut.2015.09.016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
288 Yokoyama S, Takahashi S, Kawakami Y, Hayes CN, Kohno H, Kohno H, Tsuji K, Aisaka Y, Kira S, Yamashina K, Nonaka M, Moriya T, Kitamoto M, Aimitsu S, Nakanishi T, Kawakami H, Chayama K. Effect of vitamin D supplementation on pegylated interferon/ribavirin therapy for chronic hepatitis C genotype 1b: a randomized controlled trial. J Viral Hepat 2014;21:348-56. [DOI: 10.1111/jvh.12146] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
289 Skaaby T, Husemoen LL, Pisinger C, Jørgensen T, Thuesen BH, Fenger M, Linneberg A. Vitamin D status and cause-specific mortality: a general population study. PLoS One 2012;7:e52423. [PMID: 23285034 DOI: 10.1371/journal.pone.0052423] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
290 Czaja AJ. Nature and Implications of Oxidative and Nitrosative Stresses in Autoimmune Hepatitis. Dig Dis Sci 2016;61:2784-803. [PMID: 27411555 DOI: 10.1007/s10620-016-4247-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
291 Boglione L, Cusato J, De Nicolò A, Cariti G, Di Perri G, D'avolio A. Role of CYP27B1+2838 promoter polymorphism in the treatment of chronic hepatitis B HBeAg negative with PEG-interferon. J Viral Hepat 2015;22:318-27. [DOI: 10.1111/jvh.12288] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
292 Huang JF, Ko YM, Huang CF, Yeh ML, Dai CY, Hsieh MH, Huang CI, Yang HL, Wang SC, Lin ZY. 25-Hydroxy vitamin D suppresses hepatitis C virus replication and contributes to rapid virological response of treatment efficacy. Hepatol Res. 2017;47:1383-1389. [PMID: 28225575 DOI: 10.1111/hepr.12878] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
293 Lange CM, Bojunga J, Ramos-Lopez E, von Wagner M, Hassler A, Vermehren J, Herrmann E, Badenhoop K, Zeuzem S, Sarrazin C. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy. J Hepatol. 2011;54:887-893. [PMID: 21145801 DOI: 10.1016/j.jhep.2010.08.036] [Cited by in Crossref: 169] [Cited by in F6Publishing: 173] [Article Influence: 15.4] [Reference Citation Analysis]
294 Al Marzooqi SH, Feld JJ. Sorting out cirrhosis: mechanisms of non-response to hepatitis C therapy. Liver Int 2015;35:1923-33. [PMID: 25939775 DOI: 10.1111/liv.12861] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
295 Beard JA, Bearden A, Striker R. Vitamin D and the anti-viral state. J Clin Virol. 2011;50:194-200. [PMID: 21242105 DOI: 10.1016/j.jcv.2010.12.006] [Cited by in Crossref: 204] [Cited by in F6Publishing: 190] [Article Influence: 18.5] [Reference Citation Analysis]
296 Gutierrez JA, Jones KA, Flores R, Singhania A, Woelk CH, Schooley RT, Wyles DL. Vitamin D Metabolites Inhibit Hepatitis C Virus and Modulate Cellular Gene Expression. J Virol Antivir Res. 2014;3. [PMID: 26594646 DOI: 10.4172/2324-8955.1000129] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]